{
  "name" : "moscow.sci-hub.se_5411_3aa7c6f44c475d8214a297fab071d8ce_chen2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Two-dimensional non-carbonaceous materials-enabled efficient photothermal cancer therapy",
    "authors" : [ "Lianzhou Wang", "Jianlin Shi" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "N R\nT p\nY a\n2 b\nQ\na\nA R R A A\nK T P n N C\nC\nS\nh 1\nARTICLE IN PRESSG ModelANTOD-517; No. of Pages 17 Nano Today xxx (2016) xxx–xxx\nContents lists available at ScienceDirect\nNano Today\njourna l homepage: www.e lsev ier .com/ locate /nanotoday\neview\nwo-dimensional non-carbonaceous materials-enabled efficient hotothermal cancer therapy\nu Chen a,b,∗, Lianzhou Wang b, Jianlin Shi a\nState Key Laboratory of High Performance Ceramic and Superfine Microstructures, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 00050, PR China Nanomaterials Center, School of Chemical Engineering and Australia Institute for Bioengineering and Nanotechnology, University of Queensland, ueensland, 4072, Australia\nr t i c l e i n f o\nrticle history: eceived 14 November 2015 eceived in revised form 13 April 2016 ccepted 22 May 2016 vailable online xxx\neywords: wo-dimensional materials hotothermal therapy anotechnology anotoxicity ancer therapy\na b s t r a c t\nBased on the unique two-dimensional (2D) planar nanostructure with atomic-thin thickness, abundant composition variations and the corresponding exceptional physiochemical/biological performances, the emerging inorganic 2D nanomaterials with high biocompatibility have been becoming one of the most promising material nanosystems of great potentials for applications in biomedicine. This review focuses on the unique photothermal-conversion property of several new representative 2D nanomaterials beyond graphene for photothermal conversion-based tumor hyperthermia and theranostic biomedicine, including transition metal dichalcogenides (TMDCs, such as MoS2, WS2, TiS2 and Bi2Se3), black phosphorous (P), metal Pd nanosheets and their composite nanosheets. Based on high photothermal-conversion efficiency of these 2D nanomaterials, this review first highlights the design, synthesis and surface functionalization of 2D nanomaterials for photothermal therapy (PTT) ablation of cancer cells/tissues. The representative strategies of functionalizing these 2D nanomaterials for imaging-guided PTT and PTTbased synergistic cancer therapy are then discussed. The preliminary progresses on biosafety evaluation of these 2D nanomaterials were also briefly summarized and discussed. Finally, we discussed the state-ofart unsolved critical issues and challenges, and outlooked further research directions of 2D nanomaterials for potential clinical translation for PTT tumor ablation. It is believed that the fast development and promising performance of these biocompatible 2D materials can provide a highly efficient nanoplatform for combating cancer by hyperthermia.\n© 2016 Elsevier Ltd. All rights reserved.\nontents\nIntroduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00 Transition metal dichalcogenides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00\nMoS2 nanosheets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00 WS2, TiS2 and Bi2Se3 nanosheets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00 Black phosphorous nanosheets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00 Metal Pd nanosheets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00 Other 2D nanosheets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .00 2. D composite nanosheets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00 Inorganic-inorganic composite nanosheets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00 Organic-inorganic composite nanosheets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00\nBiosafety of 2D nanosheets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016.\nConclusions and outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\n∗ Corresponding author at: State Key Laboratory of High Performance Ceramic and Supe hanghai, 200050, PR China.\nE-mail address: chenyu@mail.sic.ac.cn (Y. Chen).\nttp://dx.doi.org/10.1016/j.nantod.2016.05.009 748-0132/© 2016 Elsevier Ltd. All rights reserved.\n-carbonaceous materials-enabled efficient photothermal cancer 05.009\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .00 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00\nrfine Microstructures, Shanghai Institute of Ceramics, Chinese Academy of Sciences,\nING ModelN 2 Today\nI\na a f i t i t l a r e s c t s e a n e N a l w b s a\nn d a p [ b a m c o r [ o t\nr e s r ( l i e d [ t l c w e t f t t a o\nARTICLEANTOD-517; No. of Pages 17 Y. Chen et al. / Nano\nntroduction\nHyperthermia as an efficient cancer-treatment modality has ttracted broad research attentions of scientific community on ccount of its high efficiency for cancer-cell killing and specific role or enhancing the therapeutic outcome of other treatment modalties, such as chemotherapy and radiotherapy [1]. For thermal reatment of diseases, it is facile to realize site-specific heatng effect where only the lesion tissues can be heated while he temperature of normal organs and tissues keeps at normal evel. Various heating modalities have been developed to generte the hot regions in tumors, including focused ultrasound [2–4], adiofrequency [5], magnetic field [1,6], microwave [7], light [8,9], tc. Comparatively, photothermal therapy (PTT) features low cost, ite-specific therapy, mitigated side effects and relatively high effiiency [10]. However, light-induced thermal treatment suffers from he difficulties/challenges of high light absorption of normal tisues and low light-penetration depth, which reduce the heating fficiency and cause the non-specific damage to normal tissue long light-propagation path. Fortunately, recent developments of ano-biotechnology provide a highly efficient and versatile stratgy to overcome above-mentioned critical issue to large extents. anoparticles (NPs) with high photothermal-conversion efficiency re introduced into tumor tissues, which can be activated by ight at reduced laser intensity/power density and specific laser\navelength in the first (700–980 nm) and second (1000–1400 nm) iological window [11–15]. As a result, such NPs-assisted PTT trategies can simultaneously increase the tumor-ablation efficacy nd mitigate the side effect during the hyperthermia process.\nMetal NPs such as Au nanorods, nanocages, nanostars and anoshells have been extensively developed as the earliest candiates for photothermal cancer ablation, but their optical properties re substantially influenced by their particle size, morphology, hotothermal stability and even surrounding microenvironment 13,16–18]. Carbon-based nanosystems including mesoporous caron [19–21], carbon nanodots[22,23] and graphene [24,25] were lso explored in biomedical applications, especially in phototheral therapy based on their strong light absorption in NIR region and orresponding high photothermal-conversion efficiency [26]. Some rganic, inorganic and their hybrid nanosystems, such as polypyrole [27], indocyanine green[28], conductive polymers [29], CuS 30,31], Prussian blue [32], WOx [33], black TiO2 [34] and other rganic polymer/molecules[35,36] also provide alternative phoothermal agents for PTT.\nMost of reported photothermal agents are in spherical or od-like morphology [13,16,17,37–42]. The loading capability and fficiency of these solid nanosystems are severely limited though ome cage-like shape can be created within the matrix. Fortunately, ecent results have demonstrated that inorganic two-dimensional 2D) nanosheets with ultrathin atomic thickness, controllable ateral size, and extremely large surface area exhibit unique physochemical properties suitable for a broad range of applications, specially in biomedicine such as drug/gene delivery [43–45], iagnostic imaging [46,47], photothermal/photodynamic therapy 38], biosensing[48] and even tissue engineering [49]. Compared o traditional photothermal agents, these 2D nanosheets feature ow toxicity, easy surface modification and high photothermalonversion efficiency at the wavelength within the biological indow. Graphene-based 2D nanosheets have been extensively xplored as the efficient photothermal agents for tumor hyperhermia [50]. However, graphene oxide or reduced graphene suffer rom potential toxicity and extremely low biodegradation, similar\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016\no the toxicity of carbon nanotubes [51–53]. In addition, their phoothermal efficiency should be further improved to enhance the blation outcome, which is relatively difficult to realize because f their single carbonaceous composition. The fast development\nPRESS xxx (2016) xxx–xxx\nof 2D materials recently catalyzes the emergence of a new noncarbonaceous 2D material family with high biocompatibility and enhanced photothermal-conversion efficiency, mainly including transition metal dichalcogenides (TMDCs), black phosphorous, metals and their corresponding composites (Fig. 1a). These 2D materials can be easily synthesized either by liquid exfoliation from their bulk crystals (up-down method) or growth from corresponding precursors in solution (bottom-up approach, Fig. 1a) [54–66]. The up-down approach can produce 2D nanosheets with very few defects in the materials, but it is difficult to control the morphology and uniformity of nanosheets by the exfoliation process. Comparatively, the bottom-up approach can fabricate 2D nanosheets with desirable morphology, size, dispersity and even surface modification, but it is still challenging to synthesize 2D nanosheets with single atomic-layer thickness and few defects by the bottom-up strategy, which are more suitable for biomedical applications. Importantly, either abundant chemical composition variations or subsequent functionalization processes can endow these 2D photothermal agents with bio-imaging property, i.e., these multifunctional 2D nanomateirals possess theranostic functions (concurrent diagnostic imaging and therapy) [67]. In addition, these new 2D nanosystems can realize high synergistic therapy (Fig. 1a), such as combined PTT/chemotherapy and PTT/radiation therapy (RT). As a matter of fact, a large number of 2D material nanosystems have been developed with rich composition variations and multi-facet physiochemical properties, which can circulate within the blood vessels and accumulate into tumor tissue. Upon external laser irradiation, these 2D nanosheets can convert the photo energy into thermal energy, increase the local tumor temperature and cause the tumor ablation (Fig. 1b). When they are designed and chosen for biomedical hyperthermia applications, a careful consideration should be kept in mind that there should be a good balance between biosafety and photothermal performance of these 2D materials while the biosafety is the priority (Fig. 1b). The chosen 2D materials must be highly biocompatible so that they can be potentially developed for further clinical translation. If they are toxic, it will be impossible for clinical translation no matter how high their PTT efficiency could reach.\nBased on the fast development of new 2D materials for biomedicine, herein we highlight and discuss the very recent progresses on the design, synthesis, functionalization and photothermal applications of new emerging non-carbonaceous 2D nanomaterials, focusing on their unique structure/compositionproperty relationships in tumor hyperthermia. The biosafety issues regarding short- and long-term biocompatibility evaluation of these 2D materials is briefly discussed, with a careful consideration of their structure/composition control to satisfy the practical-application requirements. Especially, the research obstacles/challenges and future developments of these promising 2D nanomaterials for clinical translation are discussed and outlooked.\nTransition metal dichalcogenides\nTransition metal dichalcogenides (TMDCs) are a new family of 2D nanosheets typically in the form of MX2 where M is the transition metal and X is the chalcogen [54,62,68]. The diverse composition choice of TMDCs enables this new material family with distinguished electronic, optical and catalytic properties, which underpin a broad spectrum of applications in energy, environmental and biomedical areas [57,69–74]. Recent results have demonstrated that certain members of TMDCs were fea-\n-carbonaceous materials-enabled efficient photothermal cancer .05.009\ntured with low cytotoxicity, high hemo/histocompatibility and high photothermal-conversion efficiency [75–81]. Especially, their high biocompatibility and biosafety guarantee their potential applications in biological- and biomedicine-related fields [82–93]. In\nARTICLE IN PRESSG ModelNANTOD-517; No. of Pages 17 Y. Chen et al. / Nano Today xxx (2016) xxx–xxx 3\nFig. 1. Summary of 2D nanosheets for PTT-based applications. (a) Schematic illustration and a summary of synthesizing 2D materials beyond graphene (e.g., TMDCs, black P ding R d the a perth\na m a i T l a w t r a\nM\na a y d c a p e\n, Pd nanocrystal and their composites) for PTT-based tumor hyperthermia, inclu epresentative scheme of in vivo PTT tumor ablation assisted by 2D nanosheets an nd photothermal performance is a key for screening 2D materials in biomedical hy\nddition to photothermal effect of TMDCs for tumor hypertheria, TMDCs with high-Z element (e.g., WS2 and Bi2Se3) can be dopted for contrast-enhanced X-ray computed tomography (CT) maging and sensitization-enhanced radiation therapy (RT) [75,94]. he unique sheet-like topology with large surface area can be utiized to encapsulate and deliver therapeutic molecules, such as nticancer drugs and therapeutic genes [95]. Moreover, TMDCs ith unprecedented physiochemical property were demonstrated o be effective in biosensing areas [77,86,96,97]. Therefore, TMDCs epresent a new 2D nanosystem for efficient tumor hyperthermia nd other specific theranostic biomedical applications [98–101].\noS2 nanosheets\nSingle-layer MoS2 nanosheets are the most representative nd explored TMDCs showing the high performance in broad pplications, mostly in electronic device, energy storage and catalsis [88,104–111]. Especially, single-layer MoS2 nanosheets show esirable characteristics of NIR absorption and high light-to-heat\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016.\nonversion efficiency, indicating that they can act as photothermal gent for PTT [112]. Importantly, MoS2 is considered to be biocomatible because Mo element is found to be an essential traceable lement for certain types of enzymes in cells and S element is\nPTT, PTT-based synergistic therapy and PPT-based theranostic nanomedicine. (b) balance between the biosafety and PTT efficiency. The balance between biosafety ermia against cancer.\nabundant in biological systems, from the viewpoint of chemical composition of TMDCs.\nMost MoS2 nanosheets were fabricated via top-down liquid exfoliation methodology from their bulk crystals. The ultrathin MoS2 nanosheets not only can act as the photothermal agent for PTT, but also function as the drug-delivery nanocarriers for chemotherapeutic agents based on their large surface area [113]. As a paradigm, an improved oleum-treatment exfoliation strategy was recently developed to fabricate 2D MoS2 nanosheets followed by surface-chitosan (CS) modification (Fig. 2a) [102]. The CSmodified MoS2 nanosheets (designated as MoS2-CS) were further demonstrated to act as NIR-triggered multifunctional nanosystem with concurrent capabilities of PTT and heat-accelerated local drug releasing. The ultrathin sheet-like shape provided abundant anchoring points to achieve high anticancer drug (doxorubicin, DOX)-loading efficiency (Fig. 2b and c) and amount (Fig. 2d). Importantly, NIR irradiation increased the microenvironment temperature of the nanosheets, further accelerating the releasing of DOX from the carrier substantially (Fig. 2e). The NIR-induced PTT\n-carbonaceous materials-enabled efficient photothermal cancer 05.009\nand concurrent enhanced chemotherapy brought with high synergistic anticancer effect between PTT and chemotherapy, achieving greatly suppressed tumor growth after such a combination of two therapeutic modalities (Fig. 2f–g) [102].\nARTICLE IN PRESSG ModelNANTOD-517; No. of Pages 17 4 Y. Chen et al. / Nano Today xxx (2016) xxx–xxx\nFig. 2. 2D MoS2 nanosheets for PTT-based tumor ablation. (a) Scheme of the synthetic procedure for MoS2-CS nanosheets and their function for anticancer-drug (DOX) loading and NIR-induced PTT. (b) Schematic illustration of DOX loading onto the surface of MoS2-CS. (c) Photographic images of DOX (left) and DOX-loaded MoS2-CS (right) solutions after (i) centrifugation and (ii) sonication. (d) DOX-loading ratio on MoS2-CS at different DOX concentrations and pH values. (e) DOX-releasing profiles in pH 5.0 PBS buffer solution with or without NIR laser irradiation at 808 nm. (f) Tumor-growth profiles after different treatments as shown in the figure. (g) Photographic image of t ty. (h) T m, (l) i\no t g i d M M [ n 1 a P 4 a t t m w\numor at the end of each treatment [102]. Copyright 2014 American Chemical Socie EM image of MoS2 nanosheets of varied particle sizes: (i) 50 nm, (j) 80 nm, (k) 100 n n figure. [103]. Copyright 2016 Elsevier.\nHowever, the crucial structural parameters of MoS2 nanosheets btained by top-down exfoliation are difficult to be precisely conrolled, and the second tedious surface-modification process is enerally required to guarantee their high stability in physiologcal condition. To solve this critical issue, we recently successfully eveloped a one-pot bottom-up strategy to synthesize PEGylated oS2 nanosheets via an one-pot solvothermal process where the o and S elements-containing precursors were involved (Fig. 2h) 103]. During the solvothermal process at high temperature, MoS2 anosheets with controllable particulate sizes (50 nm, 80 nm, 00 nm, 200 nm and 300 nm, Fig. 2i–m) were easily synthesized nd their surface PEGylation was realized simultaneously. The TT efficiency of MoS2-PEG was systematically evaluated against T1 tumor xenograft established on nude mice. After intravenous dministration of MoS2-PEG nanosheets followed by NIR irradia-\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016\nion at 808 nm, the tumor growth was substantially suppressed and he tumor was almost completely removed after the photother-\nal treatment (Fig. 2n) [103]. Importantly, no tumor recurrence as observed after PTT ablation. Such a high PTT-based therapeutic\nSchematic illustration of one-pot solvothermal synthesis of MoS2-PEG nanosheets. 200 nm and (m) 300 nm. (n) Tumor-growth profiles after each treatment as shown\noutcome shows the high potential of MoS2-PEG for clinical tumor hyperthermia or combined PTT and chemotherapy.\nThe large planar surface and high surface-to-volume ratio of MoS2 nanosheets could also be adopted for the transport of large biomolecules such as gene due to the features of easy surfaceorganic modification and efficient intracellular uptake, initiating a new gene-delivery nanosystem with 2D nanostructure beyond graphene. As a paradigm, MoS2 surface was co-modified with polyethyleneimine (PEI) and polyethylenglycol (PEG) via reducingresponsive disulfide bonds (designated as MoS2-PEI-PEG) [95]. DNA molecules were anchored onto the surface of MoS2-PEI-PEG to form a stable polyplex (designated as MoS2-PEI-PEG/DNA). The as-synthesized MoS2-PEI-PEG/DNA entered the cells via a typical endocytosis process. Importantly, the photothermal effect of MoS2 nanosheets by NIR irradiation was found to effectively cause the\n-carbonaceous materials-enabled efficient photothermal cancer .05.009\nendosomal escape of MoS2-PEI-PEG/DNA and enter the cytoplasm of cells afterwards. The reducing microenvironment (in the presence of glutathione, GSH) induced the detachment of PEI-PEG/DNA from the carrier for subsequent efficient gene transfection. In this\nARTICLE IN PRESSG ModelNANTOD-517; No. of Pages 17 Y. Chen et al. / Nano Today xxx (2016) xxx–xxx 5\nF for Mo t ment W\nr i s r e t e 2 a\nW\nt i n W w o P w F s n F P t\n(\nt\nig. 3. 2D MoS2 nanosheets for gene delivery. The scheme of synthetic procedure riggered endosomal escape and subsequent redox-responsive PEI-PEG/DNA detach\neinheim.\negard, 2D MoS2 carrier exerted two specific roles. One is efficient ntracellular uptake and the other is photothermal effect for endoomal escape (Fig. 3). Such a photothermal-medicated endosomal upture responsive to laser irradiation represents an alternative but fficient route to improve the gene-delivery efficiency of nanosysems based on the specific physiological property (photothermal ffect in this case) of the carrier, initiating a new paradigm of D photothermal-conversion nanomaterials for gene-therapeutic pplications.\nS2, TiS2 and Bi2Se3 nanosheets\nBy optimizing the composition of 2D TMDCs, they could act as heranostic agents for imaging-guided PTT ablation of tumor. For nstance, WS2 nanosheets (Fig. 4a) with high-content W compoent are favorable for CT imaging due to high atomic number (Z) of\nelement (Z = 74) [75]. For example, ultrathin WS2 nanosheets ere synthesized by a typical top-town exfoliation methodol-\ngy followed by surface modification with lipoic acid-conjugated EG (LA-PEG, Fig. 4a1). The initial thickness of WS2 nanosheets as around 1.1 nm measured by atomic force microscopy (AFM, ig. 4a2–a4), which was slightly increased to around 1.6 nm after urface PEGylation. Intravenous administration of PEGylated WS2 anosheets improved the contrast-enhanced CT imaging of tumor. or PTT, either intratumor or intravenous administration of WS2EG quickly elevated the tumor temperature (Fig. 4a5), inhibited\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016.\nhe tumor growth (Fig. 4a6) and promoted the survival of mice\nFig. 4a7). In addition to mostly explored MoS2 and WS2 nanosheets, itanium dichalcogenides (TiS2) nanosheets were also recently\nS2-PEI-PEG/DNA and their sequential delivery of plasmid DNA via photothermaland DNA transfection. [95]. Copyright 2016 WILEY-VCH Verlag GmbH & Co. KGaA,\ndemonstrated to be effective in photothermal conversion for tumor hyperthermia (Fig. 4b) [114]. In addition, their exceptional photoacoustic responsiveness endows them with PA imaging-guided photothermal potential (Fig. 4b1). Ti component in TiS2 was considered to be more biocompatible compared to Mo and W elements in MoS2 and WS2, respectively, because Ti-based biomaterials have found extensive clinical applications. TiS2 nanosheets were prepared by a bottom-up approach, during which TiC4 precursor reacted with sulfur powder at high temperature. The particle size of as-synthesized TiS2 nanosheets was around 100 nm (Fig. 4b2). Their surface was further PEGylated via a hydrophobic interaction between PEG molecules and TiS2 surface. Especially, the extinction coefficient of TiS2-PEG at 808 nm was determined to be as high as 26.8 Lg−1 cm−1, comparable to MoS2 and WS2 nanosheets. The high PA-imaging capability of TiS2 nanosheets was demonstrated after intravenous administration of TiS2-PEG nanosheets where strong contrast-enhanced PA signals were observed within the whole tumor, showing the imaging-guidance capability. In vivo evaluation on photothermal efficiency showed that the tumor temperature increased quickly after intravenous administration of TiS2-PEG nanosheets followed by 808 nm laser irradiation (0.8 W/cm2, 5 min). The tumor growth was drastically inhibited (Fig. 4b3) and the survival rate was substantially improved (Fig. 4b4). The tumor was almost completely removed after photothermal ablation assisted by TiS2-PEG (Fig. 4b5). Besides, bismuth selenide (Bi2Se3) nanosheets (Fig. 4c) with particulate size of around 90 nm\n-carbonaceous materials-enabled efficient photothermal cancer 05.009\n(Fig. 4c1) were recently shown as photothermal agents for efficient PTT [94]. As a typical evaluation, the temperature of Bi2Se3 aqueous solution increased significantly after 808 nm laser irradiation (1 W/cm2, Fig. 4c2). High in vivo PTT efficiency was verified\nARTICLE IN PRESSG ModelNANTOD-517; No. of Pages 17 6 Y. Chen et al. / Nano Today xxx (2016) xxx–xxx\nFig. 4. 2D WS2, TiS2 and Bi2Se3 nanosheets for PTT-based tumor ablation. (a) 2D WS2 nanosheets for photothermal therapy. (a1) Schematic illustration of synthetic procedure for WS2 nanosheets and their further surface PEGylation. AFM images of (a2) WS2 and (a3) WS2-PEG. (a4) Thickness of WS2 and WS2-PEG nanosheets obtained from the statistic result of AFM image. (a5) Infrared thermal image of mice after intratumoral and intravenous administrations of WS2-PEG nanosheets. (a6) Tumor-volume growth and (a7) survival rate of tumor-bearing mice after different treatments. [75]. Copyright 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. (b) 2D TiS2 nanosheets for photothermal therapy. (b1) The scheme of synthesizing PEGylated TiS2 nanosheets for PA imaging-guided photothermal therapy. (b2) TEM image of TiS2 nanosheets. (b3) Tumor-volume changes and (b4) survival rates as functions of therapeutic time duration after different treatments as shown in the figures. (b5) Photographic images of tumorbearing mouse immediately and 10 d after the PTT treatment, showing almost complete removal of tumor. [114]. Copyright 2015 Royal Society of Chemistry. (c) 2D Bi2Se3 n . (c2) t r-volu s\na i\nt p t t a s d a W s I c w u p\n(\nanosheets for photothermal tumor ablation. (c1) TEM image of Bi2Se3 nanosheets ime at different concentrations (a-e in figure: 0, 5, 10, 20 and 50 g/mL). (c3) Tumo hown in the figure. [94]. Copyright 2013 Nature Publishing Group.\nfter intratumor injection of Bi2Se3 nanosheets followed by laser rradiation against H22 tumor (Fig. 4c3).\nAlthough PTT showed relatively high efficiency for tumor reatment, its therapeutic outcome is severely restricted by lightenetration depth where tumors within deep organs are difficult o be irradiated by light, causing the incomplete eradication of umor cells/tissues and low therapeutic efficiency. Synergistic therpy combing two or more therapeutic modalities is expected to olve this critical issue. On this ground, ultrasmall WS2 QDs were esigned as both radiosensitizer and photothermal-conversion gent for simultaneous RT and PTT [115]. The high Z number of\ncomponent in WS2 QDs endows them as promising radiosenitizer for RT and NIR-absorbance capability is suitable for PTT. t is noted that PTT is reported to be effective in killing the caner cells those are not sensitive to RT procedure [116]. WS2 QDs\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016\nere fabricated by combined exfoliation process and continuous ltrasonication to drastically reduce the particle size (Fig. 5a). The article size of as-synthesized WS2 QDs was only around 3 nm\nFig. 5b), which is favorable for potential renal clearance out of\nTemperature increase of Bi2Se3 aqueous solution as a function of laser-irradiation me change as a function of therapeutic time duration after different treatments as\nthe body. The photothermal-conversion efficiency of WS2 QDs was calculated to be as high as 44.3%. In vivo tumor-xenograft experiment demonstrated that the combination of PTT and RT after the intravenous administration of WS2 QDs induced high synergistic effect where the tumors could be almost completely eliminated in five days after combined PTT and RT therapy without detectable recurrence (Fig. 5c and d). This result shows that simple choice of the composition of TMDCs can endow these nanosheets with multifunctionality for combined cancer therapy, including abovementioned simultaneous PTT and RT.\nBlack phosphorous nanosheets\nAs a new emerging 2D layer-structured material, black phosphorous (designated as BP) can be exfoliated to form ultrathin\n-carbonaceous materials-enabled efficient photothermal cancer .05.009\n2D nanosheets, attracting extensive applications of scientific community due to their unprecedented property and promising application in broad applications [119–122]. The phosphorous element is a necessary component of human body, showing the high\nARTICLE IN PRESSG ModelNANTOD-517; No. of Pages 17 Y. Chen et al. / Nano Today xxx (2016) xxx–xxx 7\nF WS2 Q s T and\nb r p a\nt e s l s p i 8 h g W c t H B e c c c w l m t\nB p B t s o w ( w o a m r ( w\nig. 5. 2D WS2 QDs for PTT-based tumor ablation. (a) The scheme of synthesizing hown in the figure. (d) Photographic image of tumor-bearing mice at the end of PT\niocompatibility in the specific allotrope of phosphorous. Very ecently, BP nanosheets were demonstrated to act as exceptional hotothermal-conversion agent for efficient tumor hyperthermia nd photosensitizer for photodynamic therapy [117,118].\nHighly dispersed BP quantum dots (designated as BPQDs) with he lateral size of around 2.6 m were synthesized by direct liquid xfoliation of bulk BP crystals in 1-methyl-2-pyrrolidone (NMP) olvent under ultrasound treatment (Fig. 6a and b). Further PEGyation was conducted to improve the stability in physiological olution, which was realized by electrostatic interaction between ositively charged PEG-NH2 and negatively charged BPQDs. For n vitro photothermal assessment, the extinction coefficient at 08 nm was determined to be as high as 14.8 Lg−1 cm−1, much igher than that of traditional Au nanorods (3.9 Lg−1 cm−1) and raphene oxide nanosheets (3.6 Lg−1 cm−1) but lower than that of S2 nanosheets (23.8 Lg−1 cm−1). Importantly, the photothermalonversion efficiency of BPQDs reached 28.4%, much higher than hose of reported Au nanoshells (13%) and Au nanorods (21%). igh temperature elevation was achieved upon irradiation of PEGPQDs aqueous solution by 808 nm laser (Fig. 6c), which also xhibited high photothermal stability as shown in five on/off cirle tests (Fig. 6d). The photothermal effect of PEG-BPQDs against ancer cells was further assessed. It was found that C6 and MCF7 ancer cells were almost completely killed after the co-incubation ith PEG-BPQDs at concentration of 50 ppm followed by 808 nm aser irradiation at 1.0 W/cm2 (Fig. 6e). The high in vitro phototheral efficiency and ultrasmall particulate sizes of BPQDs is expected o guarantee further in vivo efficient tumor hyperthermia. In addition to photothermal effect for tumor hyperthermia, P nanosheets could function as the efficient photosensitizer for hotodynamic tumor therapy. As an metal-free semiconductor, P nanosheets are capable of generating singlet oxygen based on heir unique electronic structure [123]. It was recently demontrated that BP nanosheets could produce 1O2 under the irradiation f entire visible light [118]. These free-standing BP nanosheets ere fabricated by stepwise swelling and exfoliation procedures Fig. 6f), which exhibited the typical sheet morphology (Fig. 6g) ith a thickness of about 2.0 nm (Fig. 6h and i). The capability f BP nanosheets for the generation of 1O2 was initially evaluted by employing 1,3-diphenylisobenzofuran (DPBF) as the probe\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016.\nolecule to react with 1O2 via a Diels-Alder 1,4-cycloaddition eaction. It was found that the laser irradiation of BP nanosheets 600 nm) gradually decomposed DPBF molecules. Its efficiency as much higher than that of bulk BP. After co-incubation of BP\nDs. (b) TEM image of WS2 QDs. (c) Tumor-volume change after each treatment as RT treatments. [115]. Copyright 2015 Americal Chemical Society.\nnanosheets with MDA-MB-231 breast cancer cells followed by laser irradiation (600 nm, 1 W/cm2, 10 min), the proliferation of cancer cells was substantially inhibited in a dose-dependent manner. IC50 was determined to be as low as 0.09 g/mL. In vivo assay showed that the tumor growth was significantly inhibited (Fig. 6j and k) and the apoptosis of tumor cells (Fig. 6l) was enhanced by intratumor injection of BP nanosheets followed by laser irradiation (660 nm, 0.5 W/cm2, 20 min), showing high in vivo photodynamic efficiency of BP nanosheets for tumor therapy. It is noted that the laser irradiation could degrade the BP nanosheets because of the instability of BP nanosheets in aqueous solution. Though this phenomenon is not favorable for photothermal or photodynamic stability of BP nanosheets, it may solve the degradability issue of traditional inorganic 2D nanosystems, which requires further systematic investigation on this decomposition and degradation issue. It is also considered that the gradual decomposition of BP nanosheets is expected to release the loaded cargos, which may establish a platform of decomposition-triggered responsive drug releasing.\nMetal Pd nanosheets\nMetal NPs, such as Au and Ag, have been extensively employed as the photothermal agents due to their unique surface plasmon resonance (SPR) effect [16,39,40,126–128]. To overcome the drawbacks of low photothermal stability of conventional plasmonic Au and Ag NPs, metal palladium (Pd) nanosheets with strong NIR SPR absorption and enhanced photothermal stability were synthesized by a generic CO-confined growth approach [124]. Highly crystallized Pd nanosheets exhibited typical nanoflake topological morphology with monodispersity and regular hexagon shape, and their edge length was controlled from 20 to 160 nm (Fig. 7a–d), highly suitable for in vivo translations. The thickness of Pd nanosheets was only 1.8 nm, less than 10 atomic layers thick. These ultrathin hexagonal Pd nanosheets exhibited tunable and strong SPR absorption (826–1068 nm) with the extinction coefficient of 4.1 × 109 M−1cm−1 (Fig. 7e). Especially, as-synthesized Pd nanosheets were highly stable upon NIR irradiation. The temperature of 1 mL of aqueous solution containing 27 ppm Pd nanosheets elevated from 28.0 ◦C to 48.7 ◦C after 10 min-irradiation by a\n-carbonaceous materials-enabled efficient photothermal cancer 05.009\nNIR laser (808 nm, 1 W cm−2; Fig. 7f). Importantly, Pd nanosheets showed low cytotoxicity even at high concentration of 600 g/mL, as demonstrated by typical MTT assay against healthy liver cells (Fig. 7 g). Significant in vitro photothermal cell-killing effect has\nARTICLE IN PRESSG ModelNANTOD-517; No. of Pages 17 8 Y. Chen et al. / Nano Today xxx (2016) xxx–xxx\nING ModelN Today\nb u\nn s h P P n o ( t t d i t ( a t i\nn p o t a t r A P t o l a t p n a\nt I c n t f i o m w r t t c q P p P n t\nO\n2 F\nARTICLEANTOD-517; No. of Pages 17 Y. Chen et al. / Nano\neen achieved by using Pd nanosheets as the photothermal agents pon 808 nm laser irradiation (Fig. 7h–j).\nPd nanosheets could function as the substrate to grow metal anoshells for functionalization. The growth of Au shell onto the urface of Pd nanosheets was realized by reducing AuPPh3Cl with ydrazine hydrate [125]. The as-synthesized core/shell structured d@Au nanosheets preserved the hexagonal morphology of initial d nanosheets, which featured with edge length of 15 nm and thickess of 1.8 nm (Fig. 7k–m). The photothermal-conversion efficiency f Pd@Au nanosheets was 28.6%, comparable to that of Au nanorods 22%) but much higher than that of Au nanoshells (13%). Integraion of Au nanoshells onto the surface of Pd nanosheets endowed he composite core/shell nanosheets with CT-imaging capability ue to high Z number of Au component. After intravenous adminstration of Pd@Au-PEG nanosheets into tumor-bearing mice (4T1 umor xenograft) at a dose of 15 mg/kg followed by laser irradiation 808 nm laser, 0.5 W/cm2), the tumor temperature elevated quickly s shown in infrared thermal image (Fig. 7n). Such a fast temperaure increase significantly inhibited the tumor growth (Fig. 7o) and mproved the mice survival (Fig. 7p).\nFurthermore, coating an Ag layer onto the surface of Pd anosheets (Pd@Ag) could improve the photothermal stability of lasmonic metal nanoplates based on high photothermal stability f inner Pd nanosheets [129]. Pre-prepared Pd nanosheets acted as he seeds to in-situ grow Ag shell by methanal to reduce AgNO3.The bsorption spectrum of Pd@Ag nanosheets was facilely tuned in he range of 971 nm to 477 nm by changing the Pd/Ag atomic atios. Upon 808 nm laser irradiation (2 W, 30 min), conventional g nanoprims underwent significant structural change while the d@Ag nanosheets exhibited almost no change, not only in strucure but also in spectrum property. The high photothermal stability f Pd@Ag nanosheets also efficiently killed the cancer cells upon aser irradiation. To facilitate the long blood-circulation duration nd easy clearance of Pd nanosheets, their particle size was reduced o as small as 4.4 nm. Not only the high photothermal efficiency was reserved (52% at 808 nm laser irradiation), these small-sized Pd anosheets quickly cleared from the mice body via renal excretion nd urine [130].\nPd nanosheets (16 nm in size) were also explored as the conrast agents for noninvasive and nonionizing PA imaging [131]. t was found that the laser irradiation (80 mW/cm2, 5 min) could ause structural collapse of Au nanorods but the structures of Pd anosheets remained almost unchanged under the same irradiaion condition, demonstrating the high stability of Pd nanosheets or PA imaging. After intravenous administration of Pd nanosheets nto mice bearing SCC7 xenograft, the contrast-enhanced signal f PA imaging gradually increased under the 790 nm laser with oderate laser energy at 4 mJ/cm2. The boundaries of tumor ere clearly distinguished in PA images. Comparatively, the mice eceived PBS only showed the PA signals of tumor skin due to he shallow penetration depth of light and low absorption conrast of tumor. The high tumor accumulation of Pd nanosheets ontributed to the high contrast enhancement of PA imaging. The uantified PA signals gave a 3.5-fold increase compared to initial A signal and remained almost unchanged up to 24 h. The high hoto-stability and contrast-enhanced PA-imaging performance of d nanosheets, together with their high biocompatibility, provide a ew type molecular probe for PA-based tumor imaging and detecion, as well as PA imaging-guided PTT of tumor.\nther 2D nanosheets\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016.\nThe research boom on 2D materials catalyzes the use of more D members for biomedical PTT applications [69,100,132–138]. or instance, magnetic iron sulfide (FeS) nanoplates with typi-\nPRESS xxx (2016) xxx–xxx 9\ncal 2D topology were developed for concurrent T2-weighted MR imaging (r2 = 209.8 mM−1s−1) and PTT by 808 nm NIR irradiation [139]. These magnetic nanoplates showed high accumulation into tumor tissue via enhanced permeability and retention (EPR) effect and high photothermal-ablation efficiency for tumor hyperthermia. 2D CuS nanoplates, as one of the most explored photothermal agents, were found to be biocompatible under sub-chronic toxicity evaluation, indicating that they could act as the potential photothermal agent for PTT-based cancer therapy [140]. In addition to above-mentioned reported 2D material nanosystems, other family members of TMDCs such as TaS2 and ceramic MXene nanosheets are also expected to be potentially effective in PTT-based cancer theranostic biomedicine [141–144]. The selection criteria of 2D nanomaterials for PTT are the rational balance between biocompatibility and photothermal-conversion efficiency under the NIR irradiation.\n2. D composite nanosheets\nInorganic-inorganic composite nanosheets\nThe integration of 2D nanosheets with functional inorganic components to form 2D composite nanosheets can bring with new funcitonalities to facilely realize imaging-guided PTT and/or PTT-based synergsitic tumor treatment. Typically, these are three strategies to realize this purpose. First, the large surface area offered by 2D nanosheets leaves sufficient room for loading of funcitonal nanocrystals where 2D nanosheets act as the substrate. Second, the framework of these 2D nanosheets can be doped with heterogenous elements for diagnostic imaging. Third, the flexible 2D naosheets could coat onto the surface of nanocrystals to form core/shell nanoparticles.\nThe integration of 2D nanosheets with other drug carriers towards multifunctionalization can also endow them with synergistic functions for simultaneous PTT and chemotherapy (Fig. 8a). Pd nanosheets were coated onto the surface of hollow mesoporous silica spheres (HMSS) via electrostatic interation (Fig. 8a1) between positively charged HMSS-NH2 ( = +29.2 mV) and negatively charged Pd nanosheet ( = −13.3 mV) [145]. A uniform layer of Pd nanosheets was found on the surface of HMSS (Fig. 8a2, 14 Pd nanosheets on each HMSS-NH2). Such an integration of Pd nanosheets endowed HMSS with strong NIR-absorption capability. Upon laser irradiaiton (808 nm, 1 W/cm2), the temperature of aqueous solution (1 mL) quickly rose from 27.0 ◦C to 47.5 ◦C at the HMSS-NH2@Pd concentration of 200 g/mL. The hollow structure and well-defined mesopores of HMSS-NH2@Pd was used as the drug (DOX) delivery nanosystem with a drug-loading capacity of 9.2%. The release kinetic of DOX from the carrier exhibited pH-dependent manner, and the exposure of carrier to NIR laser irradiation (808 nm, 1 W/cm2) fast acceletrated the drug-releasing rates due to the photothermal effect of Pd nanosheets. Cytotoxicity assay showed that the combination of chemotherapeutic effect of loaded DOX drugs and photothermal effect of coated Pd nanosheets brought with the synergistically therapeutic indexes with enhanced efficiency against Hep G2 cancer cells (Fig. 8a3). Similarly, Zheng et al. also realized the multifunctionalization of Pd@Ag nanoplate-based core/shell architecture by directly cotaing a mesoporous silica shell onto the surface of Pd@Ag for pH- and light-controlled dual-responsive drug releasing [146].\nSimilarly, the surface of 2D WS2 nanosheets were coated by a mesoporous silica layer to realize concurrent PTT and\n-carbonaceous materials-enabled efficient photothermal cancer 05.009\nchemotherapy (Fig. 8b) [147]. In addition, iron oxide nanoparticles (designated as IONPs) were pre-loaded onto the surface of WS2 before mesoporous-silica coating (Fig. 8b1). PEGylation was finally realized on the particle surface to improve the stability\nARTICLE IN PRESSG ModelNANTOD-517; No. of Pages 17 10 Y. Chen et al. / Nano Today xxx (2016) xxx–xxx\nFig. 8. Composite nanosheets by integrating with mesoporous silica. (a) Synthesis of Pd nanosheet-coated HMSNs for simultaneous PTT and chemotherapy. (a1) The scheme of synthetic procedure for Pd nanosheet-coated HMSS. (a2) TEM image of HMSS-NH2@Pd; (a3) Cell viabilities of Hep G2 cells after incubation with free DOX and HMSSNH2/Dox@Pd with or without laser irradiation. [145]. Copyright 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. (b) Synthesis of WS2-IO@MS-PEG for theranostic a WS2t or-gr ( pyrig\no W I w M c c i c p a e e o a ( p n s t i i\nm a o\npplications. (b1) Schematic illustration of the synthetic procedure for DOX-loaded umor-bearing mice after different treatments followed by laser irradiation. (b4) Tum b5) Photographic image of tumors of each group at the end of treatments. [147]. Co\nf carriers (designated as WS2-IO@MS-PEG). In WS2-IO@MS-PEG, S2 nanosheets realized PTT and CT imaging, and integrated\nONPs acted as the CAs for T2-weighted MR imaging, i.e., they ere designed for CT/MRI dual-modality diagnostic imaging. oreover, mesoporous silica shell could store and deliver antiancer drugs (DOX). Uniform particle distribution and obvious ore/shell structure of WS2-IO@MS-PEG were revealed in TEM mage (Fig. 8b2). After IONPs integration and mesoporous-silica oating, WS2-IO@MS-PEG composite nanosheets preserved high hotothermal efficiency and stability. The laser irradiation further ccelerated DOX releasing from mesopores due to photothermal ffect. The integration of IONPs exhibited relatively high contrastnhanced T2-weighted MRI property with transverse relaxivity (r2) f 121.5 mM−1s−1. In vivo evaluation exhibited that intravenous dministration of WS2-IO@MS-PEG followed by laser irradiation 808 nm laser) quickly raised the tumor temperature at low laser ower density (0.55 W/cm2, 10 min, Fig. 8b3). Importantly, simultaeous PTT and DOX-delivery mediated by WS2-IO@MS-PEG caused ynergistic therapeutic effect with the highest inhibition rate of umor growth (Fig. 8b4 and b5), showing the multifunctionalty of WS2-IO@MS-PEG composite nanosheets for multi-modality maging-guided synergistic PTT and chemotherapy.\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016\nIt was considered that bismuth (Bi) is a biocompatible eleent with high atomic number (Z), which features with high X-ray ttenuation for CT imaging and strong photoelectric absorbance f X-ray radiation for radiotherapy sensitization [150–152]. On\nIO@MS-PEG. (b2) TEM image of WS2-IO@MS-PEG. (b3) Infrared thermal images of owth profiles as a function of time after different treatments as shown in the figure. ht 2015 Elsevier.\nthis ground, Bi2S3 nanoparticles-integrated MoS2 nanosheets were recently fabricated for simultaneous RT sensitization and PTT enhancement [148]. A one-pot solvothermal method was developed for synthesizing PEGylated MoS2/Bi2S3 composite nanosheets (MoS2/Bi2S3-PEG, designated as MBP). The extra introduction of S and Bi content in (NH4)2MoS4 reaction system in-situ grew Bi2S3 nanoparticles onto the surface of MoS2 nanosheets (Fig. 9a). The average particle size of MBP nanosheets with sheet morphology was around 300 nm with integrated 10 nm-sized Bi2S3 nanoparticles (Fig. 9b–d). The integration of Bi2S3 nanoparticles would not change the photothermal efficiency of initial MoS2 nanosheets as demonstrated by fast temperature elevation of MBP aqueous solution after laser irradiation (Fig. 9e). Synergistic in vivo therapeutic outcome was achieved by combination of RT sensitization by integrated Bi2S3 nanoparticles and PTT by MoS2 nanosheets where the tumor growth was significantly inhibited and survival rate of mice was substantially improved based on this synergistic effect (Fig. 9f–h). This bottom-up nanoparticle-decoration strategy provides a versatile strategy to improve the therapeutic efficiency of single PTT tumor ablation by combination of PTT and RT.\nThe unique planar nanostructure of 2D nanosheets provides abundant anchoring points for integrating multiple guest\n-carbonaceous materials-enabled efficient photothermal cancer .05.009\nmolecules and nanoparticles. In this regard, 2D MoS2 nanosheets were initially functionalized with IONPs for T2-weighted MR imaging, followed by absorption of a commonly used positron-emitting radioisotope 64Cu for positron emission tomography (PET) imaging\nARTICLE IN PRESSG ModelNANTOD-517; No. of Pages 17 Y. Chen et al. / Nano Today xxx (2016) xxx–xxx 11\nFig. 9. Nanoparticle-integrated composite nanosheets for PTT. (a) The scheme of synthetic procedure for MoS2/Bi2S3-PEG (MBP). (b) TEM, (c) HRTEM and (d) SEM images of MBP. (e) Temperature increases of MBP aqueous solution at different Mo concentrations upon 808 nm laser irradiation for 300 s. (f) Tumor-growth profiles and (g) survival rate of mice after different treatments. (h) Photographic image of tumors of each group at the end of treatment. [148]. Copyright 2015 WILEY-VCH Verlag GmbH & Co. KGaA, W image t or-bea [\n( M p t i f s s t t S i t ( r e\neinheim. (i) The scheme of synthesizing 64Cu-labelled MoS2-IO-(d)PEG. (j) TEM esting magnetization hysteresis loops. (l) PET, (m) PA and (n) MR imaging of tum 149]. Copyrigt 2015 American Chemical Society.\nFig. 9i) [149]. In addition, the excellent NIR-absorption property of oS2 nanosheets was used for PA imaging. In this regard, the comosite MoS2 nanosheets (designated as MoS2-IO-(d)PEG) realized riple-modality diagnostic imaging, i.e., concurrent PA, MR and PET maging. The synthesized MoS2-IO-(d)PEG composite nanosheets eatured planar morphology with obvious integrated IONPs on the urface (Fig. 9j), which also exhibited superparamagnetic property uitable for MR imaging (Fig. 9k). PET scanning results showed that he injection of 64Cu-labelled MoS2-IO-(d)PEG exhibited obvious umor-contrast enhancement due to EPR effect of tumor (Fig. 9l). imilarly, significant PA signals were observed in tumors after the njection of MoS2-IO-(d)PEG (Fig. 9m). MRI results also showed hat a contrast-enhanced T signal appeared by using MoS -IO-\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016.\n2 2 d)PEG as contrast agents (Fig. 9n), in consistent with PET and PAT esults. Importantly, the photothermal effect of MoS2 matrix also ffectively inhibited the tumor growth after laser irradiation.\nof MoS2-IO-(d)PEG. (k) Magnetic property of IONPs-loaded MoS2 nanosheets by ring mice after administration of 64Cu-labelled MoS2-IO-(d)PEG nanocomposites.\nBottom-up synthesis can realize the doping of heterogeneous elements into the structure of 2D nanosheets to achieve the specific functions, which is difficult to be realized by typical top-down exfoliation process. On this ground, 2D WS2 nanoflakes were successfully doped with various types of metal ions simply by a high-temperature solution reaction, during which WCl6 and MClx (M = Fe3+, Co3+, Ni2+, Mn2+ and Gd3+) reacted with sulfur in oleylamine and 1-octadecene mixtures (Fig. 10a) [153]. Further PEGylation was carried out to improve the stability of doped WS2 nanosheets in physiological solution. As a paradigm, Gd3+-doped WS2 nanosheets (designated as WS2:Gd3+) were demonstrated to be highly effective in cancer theranostics, including triple diagnostic imaging and synergistic PTT and RT. The PEGylated WS :Gd3+\n-carbonaceous materials-enabled efficient photothermal cancer 05.009\n2 exhibited small particle size of around 80 nm (Fig. 10b), The mass extinction coefficient of WS2:Gd3+-PEG was determined to be 22.6 Lg−1cm−1, much higher than that of graphene oxide (3.6\nARTICLE IN PRESSG ModelNANTOD-517; No. of Pages 17 12 Y. Chen et al. / Nano Today xxx (2016) xxx–xxx\nFig. 10. Composite nanosheets by metal-ion doing for PTT. (a) Synthetic procedure for metal element-doped WS2 nanosheets and further surface PEGylation. (b) TEM image of PEGylated WS :Gd3+ nanoflaks. Representative in vivo triple-modality diagnostic imaging of mice bearing 4T1 tumors after intravenous administration of WS:Gd3+-PEG, i T1 tum f Tumo fi\nL c w h T i f t I t c g e\nO\nn v c a e f s n c a s o\n2\nncluding (c) CT, (d) MR and (e) PA imagings. (f) In vivo infrared thermal imaging of 4 ollowed by laser irradiation for different durations (808 nm laser, 0.5 W/cm2). (g) gure. [153]. Copyright 2015 American Chemical Society.\ng−1cm−1), showing high photothermal-conversion efficiency. Effiient in vivo triple-modality diagnostic imaging was demonstrated ithin tumor tissue because of the presence of W component with igh atomic number (Z) for CT imaging (Fig. 10c), Gd3+-doping for 1-weighted MR imaging (Fig. 10d) and NIR absorption for PA imagng (Fig. 10e). High photothermal effect of WS2:Gd3+-PEG induced ast temperature increase of tumor after intravenous administraion of nanosheets followed by 808 nm laser irradiation (Fig. 10f). mportantly, the high Z of W element in WS2 nanosheets made hem as efficient sensitization agent to boost the RT of tumor, ausing the synergistic effect in combination with PTT. The tumor rowth was almost completely inhibited based on such a high synrgistic effect (Fig. 10g).\nrganic-inorganic composite nanosheets\nIt was considered that intravenous administration of 2D anosheets only caused a trace amount of nanosheets into tumor ia the typical EPR effect, which is now considered as the biggest hallenge of nanoparticles for tumor treatment. Even with the ssistance of active targeting, the delivery efficiency was still genrally lower than 10%. Therefore, the PTT efficiency should be urther enhanced and the potential biosafety issue should be conidered on account of whole-body distribution of administrated anosheets. Comparatively, intratumor injection of 2D nanosheets\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016\nan enhance the sheet accumulation within tumor, but it unavoidbly diffuses into the blood stream because of the small particle ize of 2D nanosheets. To solve this critical issue, we recently develped an organic-inorganic hybrid system, i.e., 2D MoS2-embeded\nor-bearing mice without (control group) and with the administration of WS2:Gd3+ r-volume change as a function of time after different treatments as noted in the\npoly(lactic-co-glycolic acid) (PLGA) oleosol, for intelligent localized tumor therapy [154]. FDA-approved PLGA could be easily dissolved into an biocompatible organic N-methylpyrrolidone (NMP) solvent, in which MoS2 nanosheets was dispersed and anticancer drug DOX was concurrently dissolved, forming PLGA/MoS2/DOX (designated as PMD) composite oleosol. When this injectable PMD oleosol was injected into aqueous solution, the NMP solvent quickly diffused into surrounding solution, after which hydrophobic PLGA in-situ formed a solid implant containing MoS2 nanosheets and DOX drugs (Fig. 11a). The as-formed PMD implant firmly restricted within tumor tissue. After 808 nm laser irradiation, the photothermal effect of encapsulated MoS2 nanosheets quickly raised the temperature of surrounding solution (Fig. 11b and c), and accelerated the DOX releasing from PMD implant (Fig. 11d). The in-situ formed PMD implant induced high synergistic-therapeutic effect combining PTT and chemotherapy, causing the significant inhibition of tumor growth (Fig. 11e). Importantly, the as-formed PMD implant is biodegradable with the implanting time. It is also noted that such an injection mode based on liquid-solid phase-changing implants can firmly restrict the photothermal agents within the tumor tissue, thus the cytotoxicity to normal organs is significantly mitigated [6].\nBiosafety of 2D nanosheets\n-carbonaceous materials-enabled efficient photothermal cancer .05.009\nAll above-mentioned 2D material nanosystems have just been introduced into biomedicine very recently, which means that the biosafety evaluation and data are still in infancy and extremely rare. However, the biosafety is the priority of paramount importance to\nARTICLE IN PRESSG ModelNANTOD-517; No. of Pages 17 Y. Chen et al. / Nano Today xxx (2016) xxx–xxx 13\nFig. 11. 2D nanosheets-based implant for PTT-based tumor ablation. (a) The scheme of fabricating PMDs for localized tumor-synergistic therapy. The temperature increase o 808 n d mice V\nc f e b o n\nn i W [ B o c s a f n u m F a o f c a\nw\nf (b) pure PMD implant and (c) saline solution with immersed PMD implant after ifferent pH values and with/without NIR irradiations. (e) Tumor-growth profiles of erlag GmbH & Co. KGaA, Weinheim.\nhoose the adequate materials valuable for biomedicine, which will urther guarantee the clinical translation. These complex biosafety valuations at least include biodegradation, cytotoxicity, biodistriution, excretion, hemocompatibility, histocompatibility to major rgans, genotoxicity and specific toxicity to reproduction system, ervous system and embryonic system [155–158].\nFortunately, aforementioned 2D nanosystems have showed o obvious toxicity via preliminary biosafety evaluation. For\nnstance, biocompatibility evaluation of PEGylated MoS2 and S2 nanosheets has been conducted either in vitro or in vivo 102,113,154,159]. For black phosphorous (BP), the cytotoxicity of PQDs was assessed by a standard MTT assay against four types f cells, including HSC, 293T, C6 and MCF7 cells [117]. No obvious ytotoxicity was found even at a high concentration of 200 ppm, howing relatively high biocompatibility of BPQDs. The particle size nd surface chemistry substantially influence the particle excretion rom the body. For instance, GSH-modified Pd nanosheets with 4.4 m-particulate sizes were found to be rapidly cleared by renal and rine [130]. Comparatively, 2D nanosheets with large particle sizes ore than 10 nm are difficult to be excreted by renal system. 2D eS nanoplates were found to be gradually excreted out of the body fter intravenous injection. Even at dose of as high as 100 mg/kg, no bvious toxic effect was observed [139]. 2D CuS nanoplates were ound to show low-level toxicity against HUVEC and RAW 264.7\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016.\nells, which showed the maximum tolerated dose of 8.66 mg/kg nd lethal dose 50 of 54.5 mg/kg, respectively [140].\nFor MoS2-based composites, the mice exhibited no obvious eight changes after receiving MoS2/Bi2S3 (MBP) nanosheets fol-\nm laser irradiation at different power densities. (d) DOX-releasing profiles under after different treatments as noted in the figure. [154]. Copyright 2015 WILEY-VCH\nlowed by either PTT or X-ray irradiation or combined PTT/X-ray irradiation (Fig. 12a) [148]. MBP nanosheets were gradually cleared from the body as demonstrated by the biodistribution study of Mo for different durations where the Mo content in major organs decreased with feeding time (Fig. 12b). Hemocompatibility evaluation showed that there were no differences on prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (FIB) and thrombin time (TT) of plasma after the comparison of mice with and without the administration of MBP (Fig. 12c). The biochemistry indexes and blood parameters exhibited similar outcome (Fig. 12d–f). Histocompatibility evaluation (14 d and 40 d) showed that the administration of MBP did not induce the pathological changes of main tissues (Fig. 12g), including heart, liver, spleen, lung and kidney. Though such a biosafety evaluation is still at the preliminary stage, the biocompatibility data are intriguing and promising, showing the feasibility and potential for further extensive investigations.\nConclusions and outlook\nAs a new emerging nanosystem for biomedicine, 2D inorganic nanomaterials recently have attracted great attentions due to their intriguing performances in drug/gene delivery, biosensing, photo-thermal/dynamic therapy and diagnostic imaging. From the\n-carbonaceous materials-enabled efficient photothermal cancer 05.009\nviewpoint of structural and compositional features of 2D nanomaterials, they are considered to be more advantageous compared to the mostly explored mesoporous nanosystems with spherical morphology [3,67,160–168]. For instance, 2D nanosheets nor-\nARTICLE IN PRESSG ModelNANTOD-517; No. of Pages 17 14 Y. Chen et al. / Nano Today xxx (2016) xxx–xxx\nFig. 12. In vivo biosafety evaluation. (a) The changes of body weight of tumor-bearing mice after receiving MBP followed by either NIR or X-ray irradiation or combined N admi p us ad e H Ver\nm f r m b a p a p o r u r s\nIR/X-ray irradiations. (b) Biodistribution data of Mo from MBP after intravenous lasma, (d) blood biochemistry and (e, f) hematology data of mice after intraveno valuation by HE staining of major tissue sections. [148]. Copyright 2015 WILEY-VC\nally have large surface area and high surface-to-volume ratio or anchoring guest molecules and corresponding sustained drug eleasing [45,47], which is the typical feature of mesoporous\naterials for drug delivery [19,44,166,169–176]. Comparatively, ecause of the abundant composition variations and unique tomic-scale thickness, 2D nanosheets exhibit much more versatile hysiochemical property and superior performance for diagnosis nd therapy of diseases. This review highlights the very recent rogresses on the design, synthesis and photothermal applications f 2D inorganic nanomaterials, including TMDCs, black phosphoous, metal Pd nanosheets and their corresponding composites. The\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016\nnique photothermal-conversion capability of these 2D nanomateials enabled successful ablation for cancer cells/tissues. Their large urface area was used to deliver anticancer drugs or therapeutic\nnistration of MBP for different durations. (c) PT, FIB, APTT and TT values of blood ministration of saline as the control and MBP for 14 days. (g) Histocompatibility lag GmbH & Co. KGaA, Weinheim.\ngenes for synergistic PTT and chemotherapy. In addition, their composition was designed for simultaneous and synergistic PTT and RT. By optimizing the composition and multifunctionality of these 2D nanosystems, the theranostic performance was endowed to realize imaging-guided PTT for tumor treatment.\nConsidering the infancy nature of this research area, there are still numbers of unsolved critical issues and challenges to conquer for future clinical translations. The biodegradation and excretion issue of these 2D nanosystems are considered to be among the biggest challenges to tackle with. It is well-known that these 2D nanosheets are highly crystallized, indicating that their structure is\n-carbonaceous materials-enabled efficient photothermal cancer .05.009\nhighly integrative with very few defects. Therefore, they are commonly difficult to degrade in physiological environment. If more defects were introduced into the structure, the photothermal effi-\nING ModelN Today\nc t i e g i b c r o r i i p T p r v w f b b t b\no m w a t g d p s c a f t P e m a\nc r t b m e I b s a b a c t a\nt w i A c i n\nARTICLEANTOD-517; No. of Pages 17 Y. Chen et al. / Nano\niency would be significantly compromised. It is also considered hat the improvement of biodegradability may cause the releasng of metal ions, which is potentially toxic to human bodies at levated dosages. To solve this issue, one of the possible strateies is to reduce the whole particle sizes of these 2D nanosheets nto extremely small range, which will be easily excreted from the ody via renal system after the therapeutic process. This strategy lears the 2D nanomaterials out of the body via some specific route ather than traditional biodegradation, avoiding the accumulation f nanosheets within the body and the corresponding high toxicity isk of released metal ions. 2D black phosphorous (BP) is not stable n aqueous solution, which means that it can probably biodegrade n physiological condition. However, such structural instability will robably lead to low photothermal stability and storage difficulty. herefore, its stability should be rationally tuned to balance the hotothermal efficiency, stability and biodegradability. This work eviewed several 2D nanosheets suitable for photothermal conersion and PTT against tumor. Each 2D nanosystem is featured ith its intrinsic characteristics for tumor therapy. However, their urther clinical translation strongly relies on their biodegradation, iocompatibility and biosafety. It is highly expected that only the iodegradable 2D nanosheets with high biosafety can quickly enter he clinical stage such as black P and metal oxides though these iological evaluations are still at the very preliminary stage.\nThe photothermal efficiency should be further improved by ptimizing the nanostructure and composition of these 2D nanoaterials. The PTT outcome should be further enhanced, which ill result in largely reduced particle doses for desirable therpeutic efficiency and substantially improved biosafety of this herapeutic strategy. On one hand, new synthetic methodoloies should be explored to fabricate 2D nanosystems with esirable structure/composition-property relationships and high hotothermal-conversion property. On the other hand, adequate urface modification should be made to guarantee long bloodirculation duration, targeted transport and enhanced tumor ccumulation, which can further improve the PTT efficiency or tumor ablation. Typical PEGylation is effective for realizing hese purposes, but insufficient for satisfactorily efficient delivery. ositive-targeted drug delivery strategies specific to tumor cells is xpected by referencing the targeting strategies of other relatively ature nanosystems in biomedicine, such as liposome, micelle, lbumin and mesoporous silica nanoparticles as well. The exploration of other new 2D nanomaterials for biomedial applications is urgently required [177–186]. Although currently eported 2D nanosystems have been demonstrated to be effecive in PTT for tumor treatment, they are still not considered to e the perfect ones for biomedicine. New 2D nanosystems with ore biocompatible compositions and nanostructures are to be xplored to promote the clinical translation of 2D nanosystems. n addition, the multifunctional and hybridized strategies should e further optimized to endow these 2D nanosystems with more pecific functionalities, not just restricted to conventional MR, CT nd PA imaging [187,188]. Other advanced imaging modalities can e integrated into these 2D nanosystems. Besides chemotherapy nd RT, the photothermal property of 2D nanomaterials can be ombined with other therapeutic modalities, such as ultrasound herapy and microwave therapy, to achieve further enhanced therpeutic efficacies for PTT-based cancer treatments.\nThis is a highly multidisciplinary research area on the phoothermal applications of new 2D nanomaterials in biomedicine, hich is attracting exponentially increasing attention from chemstry, physics, material science, biology and biomedicine fields.\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016.\nlthough it is now still at its preliminary stage, the high PTT effiiency and therapeutic outcome assisted by these 2D nanomaterials ndeed provide great promise and prospect of translating these 2D anomaterials to clinical cancer therapy. Of course the biomedi-\nPRESS xxx (2016) xxx–xxx 15\ncal applications of these 2D inorganic nanomaterials are not only restricted to PTT of tumor hyperthermia, their broad applications in biomedicine such as biosensing, antibacterial and tissue engineering are also highly promising but out of the scope of this review. It is strongly believed that these 2D nanomaterials will spark broader interests in scientific communities and find the successful ways of clinical application to combat cancer.\nAcknowledgements\nWe greatly acknowledge the financial support from National Nature Science Foundation of China (Grant No. 51302293 and 51132009), Natural Science Foundation of Shanghai (Grant No. 13ZR1463500), Shanghai Rising-Star Program (Grant No. 14QA1404100), Youth Innovation Promotion Association (Grant No. 2013169), Institute Hundred-Talent Program of SICCAS, Development Fund for Shanghai Talents (2015), Youth Scholar of State Key Laboratory of High Performance Ceramics and Superfine Microstructures (Grant No. SKL201203), Biomedical ECR Grant 2014 of University of Queensland and ARC Discovery Early Career Research Award (No. DE160100704).\nReferences\n[1] J.H. Lee, J.T. Jang, J.S. Choi, S.H. Moon, S.H. Noh, J.W. Kim, J.G. Kim, I.S. Kim, K.I. Park, J. Cheon, Nat. Nanotechnol. 6 (2011) 418–422. [2] Y. Chen, H. Chen, J. Shi, Adv. Healthc. Mater. 4 (2015) 158–165. [3] Y. Chen, H.R. Chen, Y. Sun, Y.Y. Zheng, D.P. Zeng, F.Q. Li, S.J. Zhang, X. Wang,\nK. Zhang, M. Ma, Q.J. He, L.L. Zhang, J.L. Shi, Angew. Chem. Int. Ed. 50 (2011) 12505–12509.\n[4] X. Wang, H.R. Chen, Y. Chen, M. Ma, K. Zhang, F.Q. Li, Y.Y. Zheng, D.P. Zeng, Q. Wang, J.L. Shi, Adv. Mater. 24 (2012) 785–791. [5] M. Hiraoka, S. Jo, Y. Dodo, K. Ono, M. Takahashi, H. Nishida, M. Abe, Cancer 54 (1984) 2898–2904. [6] Y. Chen, L. Jiang, R. Wang, M. Lu, Q. Zhang, Y. Zhou, Z. Wang, G. Lu, P. Liang, H. Ran, H. Chen, Y. Zheng, Adv. Mater. 26 (2014) 7468–7473. [7] K.T. Noell, K.T. Woodward, B.T. Worde, R.I. Fishburn, L.S. Miller, Cancer 45 (1980) 638–646. [8] D.P. O’Neal, L.R. Hirsch, N.J. Halas, J.D. Payne, J.L. West, Cancer Lett. 209 (2004) 171–176. [9] Z. Zhang, L. Wang, J. Wang, X. Jiang, X. Li, Z. Hu, Y. Ji, X. Wu, C. Chen, Adv. Mater. 24 (2012) 1418–1423.\n[10] L. Cheng, C. Wang, L. Feng, K. Yang, Z. Liu, Chem. Rev. 114 (2014) 10869–10939. [11] M.-F. Tsai, S.-H.G. Chang, F.-Y. Cheng, V. Shanmugam, Y.-S. Cheng, C.-H. Su, C.-S. Yeh, ACS Nano 7 (2013) 5330–5342. [12] A.M. Smith, M.C. Mancini, S. Nie, Nat. Nanotechnol. 4 (2009) 710–711. [13] P.K. Jain, X.H. Huang, I.H. El-Sayed, M.A. El-Sayed, Acc. Chem. Res. 41 (2008)\n1578–1586. [14] A.M. Alkilany, L.B. Thompson, S.P. Boulos, P.N. Sisco, C.J. Murphy, Adv. Drug\nDeliv. Rev. 64 (2012) 190–199. [15] P. Vijayaraghavan, C.H. Liu, R. Vankayala, C.S. Chiang, K.C. Hwang, Adv.\nMater. 26 (2014) 6689–6695. [16] S.E. Skrabalak, J.Y. Chen, Y.G. Sun, X.M. Lu, L. Au, C.M. Cobley, Y.N. Xia, Acc.\nChem. Res. 41 (2008) 1587–1595. [17] X.H. Huang, S. Neretina, M.A. El-Sayed, Adv. Mater. 21 (2009) 4880–4910. [18] S.E. Skrabalak, J. Chen, L. Au, X. Lu, X. Li, Y.N. Xia, Adv. Mater. 19 (2007)\n3177–3184. [19] Y. Chen, P. Xu, M. Wu, Q. Meng, H. Chen, Z. Shu, J. Wang, L. Zhang, Y. Li, J. Shi,\nAdv. Mater. 26 (2014) 4294–4301. [20] Y. Chen, J. Shi, Sci. China Mater. 58 (2015) 241–257. [21] S. Zhang, X. Qian, L. Zhang, W. Peng, Y. Chen, Nanoscale 7 (2015) 7632–7643. [22] H. Li, Z. Kang, Y. Liu, S.-T. Lee, J. Mater. Chem. 22 (2012) 24230–24253. [23] Q. Kong, L. Zhang, J. Liu, M. Wu, Y. Chen, J. Feng, J. Shi, Chem. Commun. 50\n(2014) 15772–15775. [24] C. Chung, Y.K. Kim, D. Shin, S.R. Ryoo, B.H. Hong, D.H. Min, Acc. Chem. Res.\n46 (2013) 2211–2224. [25] D. Bitounis, H. Ali-Boucetta, B.H. Hong, D.H. Min, K. Kostarelos, Adv. Mater.\n25 (2013) 2258–2268. [26] G. Hong, S. Diao, A.L. Antaris, H. Dai, Chem. Rev. (2015). [27] K. Yang, H. Xu, L. Cheng, C.Y. Sun, J. Wang, Z. Liu, Adv. Mater. 24 (2012)\n5586–5592. [28] X. Zheng, D. Xing, F. Zhou, B. Wu, W.R. Chen, Mol. Pharm. 8 (2011) 447–456.\n-carbonaceous materials-enabled efficient photothermal cancer 05.009\n[29] L. Cheng, K. Yang, Q. Chen, Z. Liu, A.C.S. Nano, (2012) 5605–5613. [30] J. Mou, C. Liu, P. Li, Y. Chen, H. Xu, C. Wei, L. Song, J. Shi, H. Chen,\nBiomaterials 57 (2015) 12–21. [31] J. Mou, Y. Chen, M. Ma, K. Zhang, C. Wei, H. Chen, J. Shi, Sci. China Mater. 58\n(2015) 294–301.\nING ModelN 1 Today ARTICLEANTOD-517; No. of Pages 17 6 Y. Chen et al. / Nano\n[32] X. Jia, X. Cai, Y. Chen, S. Wang, H. Xu, K. Zhang, M. Ma, H. Wu, J. Shi, H. Chen, ACS Appl. Mater. Inter. 7 (2015) 4579–4588. [33] K. Manthiram, A.P. Alivisatos, J. Am. Chem. Soc. 134 (2012) 3995–3998. [34] W. Ren, Y. Yan, L. Zeng, Z. Shi, A. Gong, P. Schaaf, D. Wang, J. Zhao, B. Zou, H.\nYu, Adv. Healthc. Mater. (2015). [35] J.F. Lovell, C.S. Jin, E. Huynh, H. Jin, C. Kim, J.L. Rubinstein, W.C.W. Chan, W.\nCao, L.V. Wang, G. Zheng, Nat. Mater. 10 (2011) 324–332. [36] Z. Zha, X. Yue, Q. Ren, Z. Dai, Adv. Mater. 25 (2013) 777–782. [37] X.H. Huang, I.H. El-Sayed, W. Qian, M.A. El-Sayed, J. Am. Chem. Soc. 128\n(2006) 2115–2120. [38] E. Boisselier, D. Astruc, Chem. Soc. Rev. 38 (2009) 1759–1782. [39] M. Hu, J.Y. Chen, Z.Y. Li, L. Au, G.V. Hartland, X.D. Li, M. Marquez, Y.N. Xia,\nChem. Soc. Rev. 35 (2006) 1084–1094. [40] S. Lal, S.E. Clare, N.J. Halas, Acc. Chem. Res. 41 (2008) 1842–1851. [41] M.S. Yavuz, Y.Y. Cheng, J.Y. Chen, C.M. Cobley, Q. Zhang, M. Rycenga, J.W. Xie,\nC. Kim, K.H. Song, A.G. Schwartz, L.H.V. Wang, Y.N. Xia, Nat. Mater. 8 (2009) 935–939.\n[42] W.S. Seo, J.H. Lee, X.M. Sun, Y. Suzuki, D. Mann, Z. Liu, M. Terashima, P.C. Yang, M.V. McConnell, D.G. Nishimura, H.J. Dai, Nat. Mater. 5 (2006) 971–976. [43] Z. Liu, J.T. Robinson, X.M. Sun, H.J. Dai, J. Am. Chem. Soc. 130 (2008) 10876–10877. [44] Y. Chen, C. Tan, H. Zhang, L. Wang, Chem. Soc. Rev. 44 (2015) 2681–2701. [45] Y. Chen, P. Xu, Z. Shu, M. Wu, L. Wang, S. Zhang, Y. Zheng, H. Chen, J. Wang,\nY. Li, J. Shi, Adv. Funct. Mater. 24 (2014) 4386–4396. [46] K. Yang, L.L. Hu, X.X. Ma, S.Q. Ye, L. Cheng, X.Z. Shi, C.H. Li, Y.G. Li, Z. Liu, Adv.\nMater. 24 (2012) 1868–1872. [47] Y. Chen, D. Ye, M. Wu, H. Chen, L. Zhang, J. Shi, L. Wang, Adv. Mater. 26\n(2014) 7019–7026. [48] Y. Shao, J. Wang, H. Wu, J. Liu, I.A. Aksay, Y. Lin, Electroanalysis 22 (2010)\n1027–1036. [49] S. Goenka, V. Sant, S. Sant, J. Control. Release 173 (2014) 75–88. [50] J.T. Robinson, S.M. Tabakman, Y.Y. Liang, H.L. Wang, H.S. Casalongue, D.\nVinh, H.J. Dai, J. Am. Chem. Soc. 133 (2011) 6825–6831. [51] K. Kostarelos, Nat. Biotechnol. 26 (2008) 774–776. [52] S.K. Manna, S. Sarkar, J. Barr, K. Wise, E.V. Barrera, O. Jejelowo, A.C.\nRice-Ficht, G.T. Ramesh, Nano Lett. 5 (2005) 1676–1684. [53] A. Magrez, S. Kasas, V. Salicio, N. Pasquier, J.W. Seo, M. Celio, S. Catsicas, B.\nSchwaller, L. Forró, Nano Lett. 6 (2006) 1121–1125. [54] M.S. Xu, T. Liang, M.M. Shi, H.Z. Chen, Chem. Rev. 113 (2013) 3766–3798. [55] H. Li, J. Wu, Z. Yin, H. Zhang, Acc. Chem. Res. 47 (2014) 1067–1075. [56] Q. Tang, Z. Zhou, Prog. Mate. Sci. 58 (2013) 1244–1315. [57] X. Zhang, Y. Xie, Chem. Soc. Rev. 42 (2013) 8187–8199. [58] J.N. Coleman, M. Lotya, A. O’Neill, S.D. Bergin, P.J. King, U. Khan, K. Young, A.\nGaucher, S. De, R.J. Smith, I.V. Shvets, S.K. Arora, G. Stanton, H.Y. Kim, K. Lee, G.T. Kim, G.S. Duesberg, T. Hallam, J.J. Boland, J.J. Wang, J.F. Donegan, J.C. Grunlan, G. Moriarty, A. Shmeliov, R.J. Nicholls, J.M. Perkins, E.M. Grieveson, K. Theuwissen, D.W. McComb, P.D. Nellist, V. Nicolosi, Science 331 (2011) 568–571.\n[59] X. Peng, L. Peng, C. Wu, Y. Xie, Chem. Soc. Rev. 43 (2014) 3303–3323. [60] Z.Y. Zeng, Z.Y. Yin, X. Huang, H. Li, Q.Y. He, G. Lu, F. Boey, H. Zhang, Angew.\nChem. Int. Ed. 50 (2011) 11093–11097. [61] Z. Zeng, T. Sun, J. Zhu, X. Huang, Z. Yin, G. Lu, Z. Fan, Q. Yan, H.H. Hng, H.\nZhang, Angew. Chem. Int. Ed. 51 (2012) 9052–9056. [62] Q.H. Wang, K. Kalantar-Zadeh, A. Kis, J.N. Coleman, M.S. Strano, Nat.\nNanotechnol. 7 (2012) 699–712. [63] C. Tan, X. Qi, X. Huang, J. Yang, B. Zheng, Z. An, R. Chen, J. Wei, B.Z. Tang, W.\nHuang, H. Zhang, Adv. Mater. 26 (2014) 1735–1739. [64] K.S. Novoselov, D. Jiang, F. Schedin, T.J. Booth, V.V. Khotkevich, S.V. Morozov,\nA.K. Geim, Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10451–10453. [65] H. Li, G. Lu, Y. Wang, Z. Yin, C. Cong, Q. He, L. Wang, F. Ding, T. Yu, H. Zhang,\nSmall 9 (2013) 1974–1981. [66] L. Wang, T. Sasaki, Chem. Rev. 114 (2014) 9455–9486. [67] D. Chimene, D.L. Alge, A.K. Gaharwar, Adv. Mater. (2015), http://dx.doi.org/\n10.1002/adma.201502422. [68] M. Chhowalla, H.S. Shin, G. Eda, L.J. Li, K.P. Loh, H. Zhang, Nat. Chem. 5\n(2013) 263–275. [69] D. Jariwala, V.K. Sangwan, L.J. Lauhon, T.J. Marks, M.C. Hersam, ACS Nano 8\n(2014) 1102–1120. [70] X. Huang, C. Tan, Z. Yin, H. Zhang, Adv. Mater. 26 (2014) 2185–2204. [71] R. Ganatra, Q. Zhang, ACS Nano 8 (2014) 4074–4099. [72] H. Wang, H. Feng, J. Li, Small 10 (2014) 2165–2181. [73] G. Fiori, F. Bonaccorso, G. Iannaccone, T. Palacios, D. Neumaier, A. Seabaugh,\nS.K. Banerjee, L. Colombo, Nat. Nanotechnol. 9 (2014) 768–779. [74] X. Yang, J. Li, T. Liang, C. Ma, Y. Zhang, H. Chen, N. Hanagata, H. Su, M. Xu,\nNanoscale 6 (2014) 10126–10133. [75] L. Cheng, J. Liu, X. Gu, H. Gong, X. Shi, T. Liu, C. Wang, X. Wang, G. Liu, H.\nXing, W. Bu, B. Sun, Z. Liu, Adv. Mater. 26 (2014) 1886–1893. [76] C. Tan, H. Zhang, Chem. Soc. Rev. 44 (2015) 2713–2731. [77] Y. Yuan, R. Li, Z. Liu, Anal. Chem. 86 (2014) 3610–3615. [78] Q. Xi, D.M. Zhou, Y.Y. Kan, J. Ge, Z.K. Wu, R.Q. Yu, J.H. Jiang, Anal. Chem. 86\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016\n(2014) 1361–1365. [79] Z. Gu, Y. Yong, L. Zhou, L. Yan, G. Tian, X. Zheng, X. Liu, X. Zhang, J. Shi, W.\nCong, W. Yin, Y. Zhao, Nanoscale 6 (2014) 10394–10403. [80] T. Lin, L. Zhong, Z. Song, L. Guo, H. Wu, Q. Guo, Y. Chen, F. Fu, G. Chen,\nBiosens. Bioelectron. 62 (2014) 302–307.\nPRESS xxx (2016) xxx–xxx\n[81] X. Xie, D. Sarkar, W. Liu, J. Kang, O. Marinov, M.J. Deen, K. Banerjee, A.C.S. Nano, (2014) 5633–5640. [82] J.Z. Ou, A.F. Chrimes, Y.C. Wang, S.Y. Tang, M.S. Strano, K. Kalantar-zadeh, Nano Lett. 14 (2014) 857–863. [83] S. Wu, Z. Zeng, Q. He, Z. Wang, S.J. Wang, Y. Du, Z. Yin, X. Sun, W. Chen, H. Zhang, Small 8 (2012) 2264–2270. [84] J. Ge, E.-C. Ou, R.-Q. Yu, X. Chu, J. Mat. Chem. B 2 (2014) 625–628. [85] O. Lopez-Sanchez, D. Lembke, M. Kayci, A. Radenovic, A. Kis, Nat.\nNanotechnol. 8 (2013) 497–501. [86] D. Sarkar, W. Liu, X. Xie, A.C. Anselmo, S. Mitragotri, K. Banerjee, ACS Nano 8\n(2014) 3992–4003. [87] S. Ghatak, A.N. Pal, A. Ghosh, ACS Nano 5 (2011) 7707–7712. [88] A. Splendiani, L. Sun, Y. Zhang, T. Li, J. Kim, C.-Y. Chim, G. Galli, F. Wang,\nNano Lett. 10 (2010) 1271–1275. [89] X. Yang, J. Li, T. Liang, C. Ma, Y. Zhang, H. Chen, N. Hanagata, H. Su, M. Xu,\nNanoscale 6 (2014) 10126–10133. [90] T. Liu, C. Wang, W. Cui, H. Gong, C. Liang, X. Shi, Z. Li, B. Sun, Z. Liu, Nanoscale\n6 (2014) 11219–11225. [91] N. Wang, F. Wei, Y. Qi, H. Li, X. Lu, G. Zhao, Q. Xu, ACS Appl. Mater. Inter. 6\n(2014) 19888–19894. [92] S. Xu, D. Li, P. Wu, Adv. Funct. Mater. 25 (2015) 1127–1136. [93] H. Ju, L. Jia, L. Ding, J. Tian, L. Bao, Y. Hu, J.-S. Yu, Nanoscale 6 (2015)\n10394–10403. [94] J. Li, F. Jiang, B. Yang, X.R. Song, Y. Liu, H.H. Yang, D.R. Cao, W.R. Shi, G.N.\nChen, Sci. Rep. 3 (2013), Article nmuber: 1998. [95] J. Kim, H. Kim, W.J. Kim, Small (2015), http://dx.doi.org/10.1002/smll.\n201501655. [96] M. Pumera, A.H. Loo, TRAC Trend. Anal. Chem. 61 (2014) 49–53. [97] C.F. Zhu, Z.Y. Zeng, H. Li, F. Li, C.H. Fan, H. Zhang, J. Am. Chem. Soc. 135\n(2013) 5998–6001. [98] C. Tan, P. Yu, Y. Hu, J. Chen, Y. Huang, Y. Cai, Z. Luo, B. Li, Q. Lu, L. Wang, J. Am.\nChem. Soc. 137 (2015) 10430–10436. [99] H. Zhang, ACS Nano 9 (2015) 9451–9469.\n[100] G. Yang, C. Zhu, D. Du, J. Zhu, Y. Lin, Nanoscale 7 (2015) 14217–14231. [101] J. Yu, W. Yin, X. Zheng, G. Tian, X. Zhang, T. Bao, X. Dong, Z. Wang, Z. Gu, X.\nMa, Theranostics (2015), http://dx.doi.org/10.7150/thno.11802. [102] W. Yin, L. Yan, J. Yu, G. Tian, L. Zhou, X. Zheng, X. Zhang, Y. Yong, J. Li, Z. Gu,\nY. Zhao, ACS Nano 8 (2014) 6922–6933. [103] S. Wang, K. Li, Y. Chen, H. Chen, M. Ma, J. Feng, Q. Zhao, J. Shi, Biomaterials\n39 (2015) 206–217. [104] Z. Yin, H. Li, H. Li, L. Jiang, Y. Shi, Y. Sun, G. Lu, Q. Zhang, X. Chen, H. Zhang,\nACS Nano 6 (2011) 74–80. [105] Y. Li, H. Wang, L. Xie, Y. Liang, G. Hong, H. Dai, J. Am. Chem. Soc. 133 (2011)\n7296–7299. [106] H. Ramakrishna Matte, A. Gomathi, A.K. Manna, D.J. Late, R. Datta, S.K. Pati,\nC. Rao, Angew. Chem. Int. Ed. 122 (2010) 4153–4156. [107] T.F. Jaramillo, K.P. Jørgensen, J. Bonde, J.H. Nielsen, S. Horch, I. Chorkendorff,\nScience 317 (2007) 100–102. [108] Q. Xiang, J. Yu, M. Jaroniec, J. Am. Chem. Soc. 134 (2012) 6575–6578. [109] B. Radisavljevic, A. Kis, Nat. Mater. 12 (2013) 815–820. [110] C. Tan, Z. Liu, W. Huang, H. Zhang, Chem. Soc. Rev. 44 (2015) 2615–2628. [111] W. Dai, H. Dong, B. Fugetsu, Y. Cao, H. Lu, X. Ma, X. Zhang, Small 11 (2015)\n4158–4164. [112] S.S. Chou, B. Kaehr, J. Kim, B.M. Foley, M. De, P.E. Hopkins, J. Huang, C.J.\nBrinker, V.P. Dravid, Angew. Chem. Int. Ed. 52 (2013) 4160–4164. [113] T. Liu, C. Wang, X. Gu, H. Gong, L. Cheng, X. Shi, L. Feng, B. Sun, Z. Liu, Adv.\nMater. 26 (2014) 3433–3440. [114] X. Qian, S. Shen, T. Liu, L. Cheng, Z. Liu, Nanoscale 7 (2015) 6380–6387. [115] Y. Yong, X. Cheng, T. Bao, M. Zu, L. Yan, W. Yin, C. Ge, D. Wang, Z. Gu, Y.-l.\nZhao, ACS Nano (2015). [116] Q. Xiao, X. Zheng, W. Bu, W. Ge, S. Zhang, F. Chen, H. Xing, Q. Ren, W. Fan, K.\nZhao, J. Am. Chem. Soc. 135 (2013) 13041–13048. [117] Z. Sun, H. Xie, S. Tang, X.F. Yu, Z. Guo, J. Shao, H. Zhang, H. Huang, H. Wang,\nP.K. Chu, Angew. Chem. Int. Ed. 127 (2015) 11688–11692. [118] H. Wang, X. Yang, W. Shao, S. Chen, J. Xie, X. Zhang, J. Wang, Y. Xie, J. Am.\nChem. Soc. 137 (2015) 11376–11382. [119] C.M. Park, H.J. Sohn, Adv. Mater. 19 (2007) 2465–2468. [120] X. Zhang, H. Xie, Z. Liu, C. Tan, Z. Luo, H. Li, J. Lin, L. Sun, W. Chen, Z. Xu,\nAngew. Chem. Int. Ed. 54 (2015) 3653–3657. [121] J. Kang, J.D. Wood, S.A. Wells, J.-H. Lee, X. Liu, K.-S. Chen, M.C. Hersam, ACS\nNano 9 (2015) 3596–3604. [122] D. Hanlon, C. Backes, E. Doherty, C.S. Cucinotta, N.C. Berner, C. Boland, K. Lee,\nA. Harvey, P. Lynch, Z. Gholamvand, Nat. Commun. 6 (2015). [123] T. Vy, R. Soklaski, Y. Liang, L. Yang, Phys. Rev. B 89 (2014). [124] X.Q. Huang, S.H. Tang, X.L. Mu, Y. Dai, G.X. Chen, Z.Y. Zhou, F.X. Ruan, Z.L.\nYang, N.F. Zheng, Nat. Nanotechnol. 6 (2011) 28–32. [125] M. Chen, S. Tang, Z. Guo, X. Wang, S. Mo, X. Huang, G. Liu, N. Zheng, Adv.\nMater. 26 (2014) 8210–8216. [126] H.L. Qin, D. Wang, Z.L. Huang, D.M. Wu, Z.C. Zeng, B. Ren, K. Xu, J. Jin, J. Am.\nChem. Soc. 135 (2013) 12544–12547. [127] R.R. Arvizo, S. Bhattacharyya, R.A. Kudgus, K. Giri, R. Bhattacharya, P.\n-carbonaceous materials-enabled efficient photothermal cancer .05.009\nMukherjee, Chem. Soc. Rev. 41 (2012) 2943–2970. [128] P.K. Jain, I.H. El-Sayed, M.A. El-Sayed, Nano Today 2 (2007) 18–29. [129] X. Huang, S. Tang, B. Liu, B. Ren, N. Zheng, Adv. Mater. 23 (2011) 3420–3425. [130] S. Tang, M. Chen, N. Zheng, Small 10 (2014) 3139–3144.\nING ModelN Today\n[\n[\n[\n[ [\n[ [\n[\n[\n[\n[\n[\n[\n[\n[\n[ [\n[\n[\n[\n[\n[\n[\n[\n[\n[ [ [ [\n[ [\n[\n[\n[ [ [ [\n[ [\n[\n[\nARTICLEANTOD-517; No. of Pages 17 Y. Chen et al. / Nano\n131] L.M. Nie, M. Chen, X.L. Sun, P.F. Rong, N.F. Zheng, X.Y. Chen, Nanoscale 6 (2014) 1271–1276. 132] W. Hu, C. Peng, W. Luo, M. Lv, X. Li, D. Li, Q. Huang, C. Fan, ACS Nano 4 (2010) 4317–4323. 133] V. Singh, D. Joung, L. Zhai, S. Das, S.I. Khondaker, S. Seal, Prog. Mater. Sci. 56 (2011) 1178–1271. 134] Y. Liu, X. Dong, P. Chen, Chem. Soc. Rev. 41 (2012) 2283–2307. 135] C. Chung, Y.-K. Kim, D. Shin, S.-R. Ryoo, B.H. Hong, D.-H. Min, Acc. Chem. Res.\n46 (2013) 2211–2224. 136] C. Aguzzi, P. Cerezo, C. Viseras, C. Caramella, Appl. Clay Sci. 36 (2007) 22–36. 137] L.S. Lin, Z.X. Cong, J. Li, K.M. Ke, S.S. Guo, H.H. Yang, G.N. Chen, J. Mat. Chem.\nB 2 (2014) 1031–1037. 138] Q.B. Wang, W. Wang, J.P. Lei, N. Xu, F.L. Gao, H.X. Ju, Anal. Chem. 85 (2013)\n12182–12188. 139] K. Yang, G. Yang, L. Chen, L. Cheng, L. Wang, C. Ge, Z. Liu, Biomaterials 38\n(2015) 1–9. 140] W. Feng, W. Nie, Y. Cheng, X. Zhou, L. Chen, K. Qiu, Z. Chen, M. Zhu, C. He,\nNanomed. Nanotech. 11 (2015) 901–912. 141] Z. Zeng, C. Tan, X. Huang, S. Bao, H. Zhang, Energ. Environ. Sci. 7 (2014)\n797–803. 142] M. Ghidiu, M.R. Lukatskaya, M.-Q. Zhao, Y. Gogotsi, M.W. Barsoum, Nature\n(2014), http://dx.doi.org/10.1038/nature13970. 143] M.R. Lukatskaya, O. Mashtalir, C.E. Ren, Y. Dall’Agnese, P. Rozier, P.L.\nTaberna, M. Naguib, P. Simon, M.W. Barsoum, Y. Gogotsi, Science 341 (2013) 1502–1505.\n144] M. Naguib, V.N. Mochalin, M.W. Barsoum, Y. Gogotsi, Adv. Mater. 26 (2014) 992–1005. 145] W.J. Fang, S.H. Tang, P.X. Liu, X.L. Fang, J.W. Gong, N.F. Zheng, Small 8 (2012) 3816–3822. 146] W. Fang, J. Yang, J. Gong, N. Zheng, Adv. Funct. Mater. 22 (2012) 842–848. 147] G. Yang, H. Gong, T. Liu, X. Sun, L. Cheng, Z. Liu, Biomaterials 60 (2015)\n62–71. 148] S. Wang, X. Li, Y. Chen, X. Cai, H. Yao, W. Gao, Y. Zheng, X. An, J. Shi, H. Chen,\nAdv. Mater. 27 (2015) 2775–2782. 149] T. Liu, S. Shi, C. Liang, S. Shen, L. Cheng, C. Wang, X. Song, S. Goel, T.E.\nBarnhart, W. Cai, ACS Nano 9 (2015) 950–960. 150] O. Rabin, J.M. Perez, J. Grimm, G. Wojtkiewicz, R. Weissleder, Nat. Mater. 5\n(2006) 118–122. 151] M. Ma, Y. Huang, H. Chen, X. Jia, S. Wang, Z. Wang, J. Shi, Biomaterials 37\n(2015) 447–455. 152] M.-h. Yao, M. Ma, Y. Chen, X.-q. Jia, G. Xu, H.-x. Xu, H.-r. Chen, R. Wu,\nBiomaterials 35 (2014) 8197–8205. 153] L. Cheng, C. Yuan, S. Shen, X. Yi, H. Gong, K. Yang, Z. Liu, ACS Nano (2015),\nhttp://dx.doi.org/10.1021/acsnano.5b04606. 154] S. Wang, Y. Chen, X. Li, W. Gao, L. Zhang, J. Liu, Y. Zheng, H. Chen, J. Shi, Adv.\nMater. (2015), http://dx.doi.org/10.1002/adma.201503869. 155] S.J. Soenen, P. Rivera-Gil, J.-M. Montenegro, W.J. Parak, S.C. De Smedt, K.\nBraeckmans, Nano Today 6 (2011) 446–465. 156] C. Buzea, I.I. Pacheco, K. Robbie, Biointerphases 2 (2007) MR17–MR71. 157] C.F. Jones, D.W. Grainger, Adv. Drug Deliv. Rev. 61 (2009) 438–456. 158] Y. Chen, H.R. Chen, J.L. Shi, Adv. Mater. 25 (2013) 3144–3176. 159] L. Cheng, J. Liu, X. Gu, H. Gong, X. Shi, T. Liu, C. Wang, X. Wang, G. Liu, H.\nXing, Adv. Mater. 26 (2014) 1886–1893. 160] Y. Chen, H.R. Chen, J.L. Shi, Acc. Chem. Res. 47 (2014) 125–137. 161] Y. Chen, H.R. Chen, D.P. Zeng, Y.B. Tian, F. Chen, J.W. Feng, J.L. Shi, ACS Nano\n4 (2010) 6001–6013. 162] Y. Chen, Q. Meng, M. Wu, S. Wang, P. Xu, H. Chen, Y. Li, L. Zhang, L. Wang, J.\nShi, J. Am. Chem. Soc. 136 (2014) 16326–16334. 163] M.W. Ambrogio, C.R. Thomas, Y.L. Zhao, J.I. Zink, J.F. Stoddartt, Acc. Chem.\nRes. 44 (2011) 903–913. 164] J.E. Lee, N. Lee, T. Kim, J. Kim, T. Hyeon, Acc. Chem. Res. 44 (2011) 893–902. 165] F.Q. Tang, L.L. Li, D. Chen, Adv. Mater. 24 (2012) 1504–1534. 166] Y. Chen, H. Chen, J. Shi, Exp. Opin. Drug Deliv. 11 (2014) 917–930. 167] K. Kalantar-zadeh, J.Z. Ou, T. Daeneke, M.S. Strano, M. Pumera, S.L. Gras, Adv.\nFunct. Mater. 25 (2015) 5086–5099. 168] W. Zhang, J. Yu, H. Chang, J. Mat. Chem. B 3 (2015) 4959–4964.\nPlease cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016.\n169] Z.X. Li, J.C. Barnes, A. Bosoy, J.F. Stoddart, J.I. Zink, Chem. Soc. Rev. 41 (2012) 2590–2605. 170] I.I. Slowing, B.G. Trewyn, S. Giri, V.S.Y. Lin, Adv. Funct. Mater. 17 (2007) 1225–1236. 171] Y.S. Lin, K.R. Hurley, C.L. Haynes, J. Phy. Chem. Lett. 3 (2012) 364–374.\nPRESS xxx (2016) xxx–xxx 17\n[172] Y. Chen, H. Chen, J. Shi, Mol. Pharm. 11 (2014) 2495–2510. [173] Y. Chen, H. Chen, S. Zhang, F. Chen, S. Sun, Q. He, M. Ma, X. Wang, H. Wu, L.\nZhang, L. Zhang, J. Shi, Biomaterials 33 (2012) 2388–2398. [174] J.L. Shi, Y. Chen, H.R. Chen, J. Inorg. Mater. 28 (2013) 1–11. [175] Y. Chen, P.F. Xu, H.R. Chen, Y.S. Li, W.B. Bu, Z. Shu, Y.P. Li, J.M. Zhang, L.X.\nZhang, L.M. Pan, X.Z. Cui, Z.L. Hua, J. Wang, L.L. Zhang, J.L. Shi, Adv. Mater. 25 (2013) 3100–3105.\n[176] Y. Chen, H.R. Chen, L.M. Guo, J.L. Shi, J. Nanosci. Nanotechnol. 11 (2011) 10844–10848. [177] N. Liu, J. Liu, W. Kong, H. Li, H. Huang, Y. Liu, Z. Kang, J. Mat. Chem. B (2014). [178] Q. Weng, B. Wang, X. Wang, N. Hanagata, X. Li, D. Liu, X. Wang, X. Jiang, Y.\nBando, D. Golberg, ACS Nano 8 (2014) 6123–6130. [179] C. Zhi, Y. Bando, C. Tang, H. Kuwahara, D. Golberg, Adv. Mater. 21 (2009)\n2889–2893. [180] T.Y. Ma, Y. Tang, S. Dai, S.Z. Qiao, Small 10 (2014) 2382–2389. [181] H. Hu, D. Li, S. Liu, M. Wang, R. Moats, P.S. Conti, Z. Li, Biomaterials 35 (2014)\n8649–8658. [182] Z. Gu, B.E. Rolfe, Z.P. Xu, A.C. Thomas, J.H. Campbell, G.Q.M. Lu, Biomaterials\n31 (2010) 5455–5462. [183] Z. Gu, A.C. Thomas, Z.P. Xu, J.H. Campbell, G.Q. Lu, Chem. Mat. 20 (2008)\n3715–3722. [184] S. Balendhran, S. Walia, M. Alsaif, E.P. Nguyen, J.Z. Ou, S. Zhuiykov, S. Sriram,\nM. Bhaskaran, K. Kalantar-zadeh, ACS Nano 7 (2013) 9753–9760. [185] X. Zhang, H. Wang, H. Wang, Q. Zhang, J. Xie, Y. Tian, J. Wang, Y. Xie, Adv.\nMater. 26 (2014) 4438–4443. [186] X. Zhang, X. Xie, H. Wang, J. Zhang, B. Pan, Y. Xie, J. Am. Chem. Soc. 135\n(2013) 18–21. [187] J. Song, X. Yang, O. Jacobson, L. Lin, P. Huang, G. Niu, Q. Ma, X. Chen, ACS\nNano 9 (2015) 9199–9209. [188] H. Moon, D. Kumar, H. Kim, C. Sim, J.-H. Chang, J.-M. Kim, H. Kim, D.-K. Lim,\nACS Nano 9 (2015) 2711–2719.\nYu Chen received his PhD degree at Shanghai Institute of Ceramics, Chinese Academy of Sciences (SICCAS). He is now the professor and Institute Hundred-Talent Fellow in SICCAS. His research includes the design, synthesis and biomedical applications of zero-dimensional organic-inorganic hybrid mesoporous materials, twodimensional nanomaterials and three-dimensional composite implants, including mesoporous material for drug delivery, molecular probes for molecular imaging, ultrasound therapy, non-virus gene delivery vehicles and in-situ localized tumor therapy. He has published over 80 peer-reviewed articles with more than 3600 citations (h-index of 31) and filed 6 national patents.\nLianzhou Wang is currently a professor in School of Chemical Engineering and Research Director of Nanomaterials Centre, the University of Queensland (UQ), Australia. He received his PhD degree from SICCAS in 1999. Before joining UQ in 2004, he has worked at two national institutes (NIMS and AIST) of Japan for five years. Wang’s research interests include the design and application of nanostructured materials including two-dimensional layered compounds for energy, environment and relevant applications.\nJianlin Shi received his PhD degree in SICCAS. He is now the professor of SICCAS. His research areas include synthesis of mesoporous materials and mesoporous-based nano-composites, and their catalytic, biomedical and optical applications. He has published over 400 scientific papers which have been cited more than 15000 times\n-carbonaceous materials-enabled efficient photothermal cancer 05.009\nby other scientists with an h-index of 65 (2015). He was identified on Thomson Reuters “Highly cited researchers 2015” list. He has been in charge of more than 30 important research projects and has gained a number of awards for his achievements."
    } ],
    "references" : [ {
      "title" : "Nat",
      "author" : [ "J.H. Lee", "J.T. Jang", "J.S. Choi", "S.H. Moon", "S.H. Noh", "J.W. Kim", "J.G. Kim", "I.S. Kim", "K.I. Park", "J. Cheon" ],
      "venue" : "Nanotechnol. 6 ",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Adv",
      "author" : [ "Y. Chen", "H. Chen", "J. Shi" ],
      "venue" : "Healthc. Mater. 4 ",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Angew",
      "author" : [ "Y. Chen", "H.R. Chen", "Y. Sun", "Y.Y. Zheng", "D.P. Zeng", "F.Q. Li", "S.J. Zhang", "X. Wang", "K. Zhang", "M. Ma", "Q.J. He", "L.L. Zhang", "J.L. Shi" ],
      "venue" : "Chem. Int. Ed. 50 ",
      "citeRegEx" : "3",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Adv",
      "author" : [ "X. Wang", "H.R. Chen", "Y. Chen", "M. Ma", "K. Zhang", "F.Q. Li", "Y.Y. Zheng", "D.P. Zeng", "Q. Wang", "J.L. Shi" ],
      "venue" : "Mater. 24 ",
      "citeRegEx" : "4",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "M",
      "author" : [ "M. Hiraoka", "S. Jo", "Y. Dodo", "K. Ono", "M. Takahashi", "H. Nishida" ],
      "venue" : "Abe, Cancer 54 ",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 1984
    }, {
      "title" : "Adv",
      "author" : [ "Y. Chen", "L. Jiang", "R. Wang", "M. Lu", "Q. Zhang", "Y. Zhou", "Z. Wang", "G. Lu", "P. Liang", "H. Ran", "H. Chen", "Y. Zheng" ],
      "venue" : "Mater. 26 ",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Adv",
      "author" : [ "Z. Zhang", "L. Wang", "J. Wang", "X. Jiang", "X. Li", "Z. Hu", "Y. Ji", "X. Wu", "C. Chen" ],
      "venue" : "Mater. 24 ",
      "citeRegEx" : "9",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Chem",
      "author" : [ "L. Cheng", "C. Wang", "L. Feng", "K. Yang", "Z. Liu" ],
      "venue" : "Rev. 114 ",
      "citeRegEx" : "10",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "V",
      "author" : [ "M.-F. Tsai", "S.-H.G. Chang", "F.-Y. Cheng" ],
      "venue" : "Shanmugam, Y.-S. Cheng, C.-H. Su, C.-S. Yeh, ACS Nano 7 ",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Nat",
      "author" : [ "A.M. Smith", "M.C. Mancini", "S. Nie" ],
      "venue" : "Nanotechnol. 4 ",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Acc",
      "author" : [ "P.K. Jain", "X.H. Huang", "I.H. El-Sayed", "M.A. El-Sayed" ],
      "venue" : "Chem. Res. 41 ",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Adv",
      "author" : [ "A.M. Alkilany", "L.B. Thompson", "S.P. Boulos", "P.N. Sisco", "C.J. Murphy" ],
      "venue" : "Drug Deliv. Rev. 64 ",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Adv",
      "author" : [ "P. Vijayaraghavan", "C.H. Liu", "R. Vankayala", "C.S. Chiang", "K.C. Hwang" ],
      "venue" : "Mater. 26 ",
      "citeRegEx" : "15",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Acc",
      "author" : [ "S.E. Skrabalak", "J.Y. Chen", "Y.G. Sun", "X.M. Lu", "L. Au", "C.M. Cobley", "Y.N. Xia" ],
      "venue" : "Chem. Res. 41 ",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Adv",
      "author" : [ "X.H. Huang", "S. Neretina", "M.A. El-Sayed" ],
      "venue" : "Mater. 21 ",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Adv",
      "author" : [ "S.E. Skrabalak", "J. Chen", "L. Au", "X. Lu", "X. Li", "Y.N. Xia" ],
      "venue" : "Mater. 19 ",
      "citeRegEx" : "18",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Adv",
      "author" : [ "Y. Chen", "P. Xu", "M. Wu", "Q. Meng", "H. Chen", "Z. Shu", "J. Wang", "L. Zhang", "Y. Li", "J. Shi" ],
      "venue" : "Mater. 26 ",
      "citeRegEx" : "19",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Sci",
      "author" : [ "Y. Chen", "J. Shi" ],
      "venue" : "China Mater. 58 ",
      "citeRegEx" : "20",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Y",
      "author" : [ "S. Zhang", "X. Qian", "L. Zhang", "W. Peng" ],
      "venue" : "Chen, Nanoscale 7 ",
      "citeRegEx" : "21",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "H. Li", "Z. Kang", "Y. Liu", "S.-T. Lee", "J. Mater" ],
      "venue" : "22 ",
      "citeRegEx" : "22",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Chem",
      "author" : [ "Q. Kong", "L. Zhang", "J. Liu", "M. Wu", "Y. Chen", "J. Feng", "J. Shi" ],
      "venue" : "Commun. 50 ",
      "citeRegEx" : "23",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Acc",
      "author" : [ "C. Chung", "Y.K. Kim", "D. Shin", "S.R. Ryoo", "B.H. Hong", "D.H. Min" ],
      "venue" : "Chem. Res. 46 ",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Adv",
      "author" : [ "D. Bitounis", "H. Ali-Boucetta", "B.H. Hong", "D.H. Min", "K. Kostarelos" ],
      "venue" : "Mater. 25 ",
      "citeRegEx" : "25",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chem",
      "author" : [ "G. Hong", "S. Diao", "A.L. Antaris", "H. Dai" ],
      "venue" : "Rev. ",
      "citeRegEx" : "26",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Adv",
      "author" : [ "K. Yang", "H. Xu", "L. Cheng", "C.Y. Sun", "J. Wang", "Z. Liu" ],
      "venue" : "Mater. 24 ",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Mol",
      "author" : [ "X. Zheng", "D. Xing", "F. Zhou", "B. Wu", "W.R. Chen" ],
      "venue" : "Pharm. 8 ",
      "citeRegEx" : "28",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Z",
      "author" : [ "L. Cheng", "K. Yang", "Q. Chen" ],
      "venue" : "Liu, A.C.S. Nano, ",
      "citeRegEx" : "29",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "H",
      "author" : [ "J. Mou", "C. Liu", "P. Li", "Y. Chen", "H. Xu", "C. Wei", "L. Song", "J. Shi" ],
      "venue" : "Chen, Biomaterials 57 ",
      "citeRegEx" : "30",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Sci",
      "author" : [ "J. Mou", "Y. Chen", "M. Ma", "K. Zhang", "C. Wei", "H. Chen", "J. Shi" ],
      "venue" : "China Mater. 58 ",
      "citeRegEx" : "31",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Mater",
      "author" : [ "X. Jia", "X. Cai", "Y. Chen", "S. Wang", "H. Xu", "K. Zhang", "M. Ma", "H. Wu", "J. Shi", "H. Chen", "ACS Appl" ],
      "venue" : "Inter. 7 ",
      "citeRegEx" : "32",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "K. Manthiram", "A.P. Alivisatos", "J. Am" ],
      "venue" : "Soc. 134 ",
      "citeRegEx" : "33",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Adv",
      "author" : [ "W. Ren", "Y. Yan", "L. Zeng", "Z. Shi", "A. Gong", "P. Schaaf", "D. Wang", "J. Zhao", "B. Zou", "H. Yu" ],
      "venue" : "Healthc. Mater. ",
      "citeRegEx" : "34",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Nat",
      "author" : [ "J.F. Lovell", "C.S. Jin", "E. Huynh", "H. Jin", "C. Kim", "J.L. Rubinstein", "W.C.W. Chan", "W. Cao", "L.V. Wang", "G. Zheng" ],
      "venue" : "Mater. 10 ",
      "citeRegEx" : "35",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Adv",
      "author" : [ "Z. Zha", "X. Yue", "Q. Ren", "Z. Dai" ],
      "venue" : "Mater. 25 ",
      "citeRegEx" : "36",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chem",
      "author" : [ "X.H. Huang", "I.H. El-Sayed", "W. Qian", "M.A. El-Sayed", "J. Am" ],
      "venue" : "Soc. 128 ",
      "citeRegEx" : "37",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Chem",
      "author" : [ "E. Boisselier", "D. Astruc" ],
      "venue" : "Soc. Rev. 38 ",
      "citeRegEx" : "38",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Chem",
      "author" : [ "M. Hu", "J.Y. Chen", "Z.Y. Li", "L. Au", "G.V. Hartland", "X.D. Li", "M. Marquez", "Y.N. Xia" ],
      "venue" : "Soc. Rev. 35 ",
      "citeRegEx" : "39",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Acc",
      "author" : [ "S. Lal", "S.E. Clare", "N.J. Halas" ],
      "venue" : "Chem. Res. 41 ",
      "citeRegEx" : "40",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Nat",
      "author" : [ "M.S. Yavuz", "Y.Y. Cheng", "J.Y. Chen", "C.M. Cobley", "Q. Zhang", "M. Rycenga", "J.W. Xie", "C. Kim", "K.H. Song", "A.G. Schwartz", "L.H.V. Wang", "Y.N. Xia" ],
      "venue" : "Mater. 8 ",
      "citeRegEx" : "41",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Nat",
      "author" : [ "W.S. Seo", "J.H. Lee", "X.M. Sun", "Y. Suzuki", "D. Mann", "Z. Liu", "M. Terashima", "P.C. Yang", "M.V. McConnell", "D.G. Nishimura", "H.J. Dai" ],
      "venue" : "Mater. 5 ",
      "citeRegEx" : "42",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Chem",
      "author" : [ "Z. Liu", "J.T. Robinson", "X.M. Sun", "H.J. Dai", "J. Am" ],
      "venue" : "Soc. 130 ",
      "citeRegEx" : "43",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Chem",
      "author" : [ "Y. Chen", "C. Tan", "H. Zhang", "L. Wang" ],
      "venue" : "Soc. Rev. 44 ",
      "citeRegEx" : "44",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Adv",
      "author" : [ "Y. Chen", "P. Xu", "Z. Shu", "M. Wu", "L. Wang", "S. Zhang", "Y. Zheng", "H. Chen", "J. Wang", "Y. Li", "J. Shi" ],
      "venue" : "Funct. Mater. 24 ",
      "citeRegEx" : "45",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Adv",
      "author" : [ "K. Yang", "L.L. Hu", "X.X. Ma", "S.Q. Ye", "L. Cheng", "X.Z. Shi", "C.H. Li", "Y.G. Li", "Z. Liu" ],
      "venue" : "Mater. 24 ",
      "citeRegEx" : "46",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Adv",
      "author" : [ "Y. Chen", "D. Ye", "M. Wu", "H. Chen", "L. Zhang", "J. Shi", "L. Wang" ],
      "venue" : "Mater. 26 ",
      "citeRegEx" : "47",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Y",
      "author" : [ "Y. Shao", "J. Wang", "H. Wu", "J. Liu", "I.A. Aksay" ],
      "venue" : "Lin, Electroanalysis 22 ",
      "citeRegEx" : "48",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "J",
      "author" : [ "S. Goenka", "V. Sant", "S. Sant" ],
      "venue" : "Control. Release 173 ",
      "citeRegEx" : "49",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "J.T. Robinson", "S.M. Tabakman", "Y.Y. Liang", "H.L. Wang", "H.S. Casalongue", "D. Vinh", "H.J. Dai", "J. Am" ],
      "venue" : "Soc. 133 ",
      "citeRegEx" : "50",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Nat",
      "author" : [ "K. Kostarelos" ],
      "venue" : "Biotechnol. 26 ",
      "citeRegEx" : "51",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Nano Lett",
      "author" : [ "S.K. Manna", "S. Sarkar", "J. Barr", "K. Wise", "E.V. Barrera", "O. Jejelowo", "A.C. Rice-Ficht", "G.T. Ramesh" ],
      "venue" : "5 ",
      "citeRegEx" : "52",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Nano Lett",
      "author" : [ "A. Magrez", "S. Kasas", "V. Salicio", "N. Pasquier", "J.W. Seo", "M. Celio", "S. Catsicas", "B. Schwaller", "L. Forró" ],
      "venue" : "6 ",
      "citeRegEx" : "53",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Chem",
      "author" : [ "M.S. Xu", "T. Liang", "M.M. Shi", "H.Z. Chen" ],
      "venue" : "Rev. 113 ",
      "citeRegEx" : "54",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Acc",
      "author" : [ "H. Li", "J. Wu", "Z. Yin", "H. Zhang" ],
      "venue" : "Chem. Res. 47 ",
      "citeRegEx" : "55",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Prog",
      "author" : [ "Q. Tang", "Z. Zhou" ],
      "venue" : "Mate. Sci. 58 ",
      "citeRegEx" : "56",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chem",
      "author" : [ "X. Zhang", "Y. Xie" ],
      "venue" : "Soc. Rev. 42 ",
      "citeRegEx" : "57",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "A",
      "author" : [ "J.N. Coleman", "M. Lotya" ],
      "venue" : "O’Neill, S.D. Bergin, P.J. King, U. Khan, K. Young, A. Gaucher, S. De, R.J. Smith, I.V. Shvets, S.K. Arora, G. Stanton, H.Y. Kim, K. Lee, G.T. Kim, G.S. Duesberg, T. Hallam, J.J. Boland, J.J. Wang, J.F. Donegan, J.C. Grunlan, G. Moriarty, A. Shmeliov, R.J. Nicholls, J.M. Perkins, E.M. Grieveson, K. Theuwissen, D.W. McComb, P.D. Nellist, V. Nicolosi, Science 331 ",
      "citeRegEx" : "58",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Chem",
      "author" : [ "X. Peng", "L. Peng", "C. Wu", "Y. Xie" ],
      "venue" : "Soc. Rev. 43 ",
      "citeRegEx" : "59",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Angew",
      "author" : [ "Z.Y. Zeng", "Z.Y. Yin", "X. Huang", "H. Li", "Q.Y. He", "G. Lu", "F. Boey", "H. Zhang" ],
      "venue" : "Chem. Int. Ed. 50 ",
      "citeRegEx" : "60",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Angew",
      "author" : [ "Z. Zeng", "T. Sun", "J. Zhu", "X. Huang", "Z. Yin", "G. Lu", "Z. Fan", "Q. Yan", "H.H. Hng", "H. Zhang" ],
      "venue" : "Chem. Int. Ed. 51 ",
      "citeRegEx" : "61",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Nat",
      "author" : [ "Q.H. Wang", "K. Kalantar-Zadeh", "A. Kis", "J.N. Coleman", "M.S. Strano" ],
      "venue" : "Nanotechnol. 7 ",
      "citeRegEx" : "62",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Adv",
      "author" : [ "C. Tan", "X. Qi", "X. Huang", "J. Yang", "B. Zheng", "Z. An", "R. Chen", "J. Wei", "B.Z. Tang", "W. Huang", "H. Zhang" ],
      "venue" : "Mater. 26 ",
      "citeRegEx" : "63",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Proc",
      "author" : [ "K.S. Novoselov", "D. Jiang", "F. Schedin", "T.J. Booth", "V.V. Khotkevich", "S.V. Morozov", "A.K. Geim" ],
      "venue" : "Natl. Acad. Sci. U. S. A. 102 ",
      "citeRegEx" : "64",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "H",
      "author" : [ "H. Li", "G. Lu", "Y. Wang", "Z. Yin", "C. Cong", "Q. He", "L. Wang", "F. Ding", "T. Yu" ],
      "venue" : "Zhang, Small 9 ",
      "citeRegEx" : "65",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chem",
      "author" : [ "L. Wang", "T. Sasaki" ],
      "venue" : "Rev. 114 ",
      "citeRegEx" : "66",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Adv",
      "author" : [ "D. Chimene", "D.L. Alge", "A.K. Gaharwar" ],
      "venue" : "Mater. ",
      "citeRegEx" : "67",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Nat",
      "author" : [ "M. Chhowalla", "H.S. Shin", "G. Eda", "L.J. Li", "K.P. Loh", "H. Zhang" ],
      "venue" : "Chem. 5 ",
      "citeRegEx" : "68",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Adv",
      "author" : [ "X. Huang", "C. Tan", "Z. Yin", "H. Zhang" ],
      "venue" : "Mater. 26 ",
      "citeRegEx" : "70",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Q",
      "author" : [ "R. Ganatra" ],
      "venue" : "Zhang, ACS Nano 8 ",
      "citeRegEx" : "71",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "J",
      "author" : [ "H. Wang", "H. Feng" ],
      "venue" : "Li, Small 10 ",
      "citeRegEx" : "72",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Nat",
      "author" : [ "G. Fiori", "F. Bonaccorso", "G. Iannaccone", "T. Palacios", "D. Neumaier", "A. Seabaugh", "S.K. Banerjee", "L. Colombo" ],
      "venue" : "Nanotechnol. 9 ",
      "citeRegEx" : "73",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "M",
      "author" : [ "X. Yang", "J. Li", "T. Liang", "C. Ma", "Y. Zhang", "H. Chen", "N. Hanagata", "H. Su" ],
      "venue" : "Xu, Nanoscale 6 ",
      "citeRegEx" : "74",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Adv",
      "author" : [ "L. Cheng", "J. Liu", "X. Gu", "H. Gong", "X. Shi", "T. Liu", "C. Wang", "X. Wang", "G. Liu", "H. Xing", "W. Bu", "B. Sun", "Z. Liu" ],
      "venue" : "Mater. 26 ",
      "citeRegEx" : "75",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "C. Tan", "H. Zhang" ],
      "venue" : "Soc. Rev. 44 ",
      "citeRegEx" : "76",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Anal",
      "author" : [ "Y. Yuan", "R. Li", "Z. Liu" ],
      "venue" : "Chem. 86 ",
      "citeRegEx" : "77",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Anal",
      "author" : [ "Q. Xi", "D.M. Zhou", "Y.Y. Kan", "J. Ge", "Z.K. Wu", "R.Q. Yu", "J.H. Jiang" ],
      "venue" : "Chem. 86 Please cite this article in press as: Y. Chen, et al., Two-dimensional non therapy, Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016  ",
      "citeRegEx" : "78",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Y",
      "author" : [ "Z. Gu", "Y. Yong", "L. Zhou", "L. Yan", "G. Tian", "X. Zheng", "X. Liu", "X. Zhang", "J. Shi", "W. Cong", "W. Yin" ],
      "venue" : "Zhao, Nanoscale 6 ",
      "citeRegEx" : "79",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Biosens",
      "author" : [ "T. Lin", "L. Zhong", "Z. Song", "L. Guo", "H. Wu", "Q. Guo", "Y. Chen", "F. Fu", "G. Chen" ],
      "venue" : "Bioelectron. 62 (2014) 302–307.  PRESS xxx ",
      "citeRegEx" : "80",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "K",
      "author" : [ "X. Xie", "D. Sarkar", "W. Liu", "J. Kang", "O. Marinov", "M.J. Deen" ],
      "venue" : "Banerjee, A.C.S. Nano, ",
      "citeRegEx" : "81",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Nano Lett",
      "author" : [ "J.Z. Ou", "A.F. Chrimes", "Y.C. Wang", "S.Y. Tang", "M.S. Strano", "K. Kalantar-zadeh" ],
      "venue" : "14 ",
      "citeRegEx" : "82",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "H",
      "author" : [ "S. Wu", "Z. Zeng", "Q. He", "Z. Wang", "S.J. Wang", "Y. Du", "Z. Yin", "X. Sun", "W. Chen" ],
      "venue" : "Zhang, Small 8 ",
      "citeRegEx" : "83",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Chem",
      "author" : [ "J. Ge", "E.-C. Ou", "R.-Q. Yu", "X. Chu", "J. Mat" ],
      "venue" : "B 2 ",
      "citeRegEx" : "84",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Nat",
      "author" : [ "O. Lopez-Sanchez", "D. Lembke", "M. Kayci", "A. Radenovic", "A. Kis" ],
      "venue" : "Nanotechnol. 8 ",
      "citeRegEx" : "85",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "K",
      "author" : [ "D. Sarkar", "W. Liu", "X. Xie", "A.C. Anselmo", "S. Mitragotri" ],
      "venue" : "Banerjee, ACS Nano 8 ",
      "citeRegEx" : "86",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "A",
      "author" : [ "S. Ghatak", "A.N. Pal" ],
      "venue" : "Ghosh, ACS Nano 5 ",
      "citeRegEx" : "87",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Nano Lett",
      "author" : [ "A. Splendiani", "L. Sun", "Y. Zhang", "T. Li", "J. Kim", "C.-Y. Chim", "G. Galli", "F. Wang" ],
      "venue" : "10 ",
      "citeRegEx" : "88",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "M",
      "author" : [ "X. Yang", "J. Li", "T. Liang", "C. Ma", "Y. Zhang", "H. Chen", "N. Hanagata", "H. Su" ],
      "venue" : "Xu, Nanoscale 6 ",
      "citeRegEx" : "89",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Z",
      "author" : [ "T. Liu", "C. Wang", "W. Cui", "H. Gong", "C. Liang", "X. Shi", "Z. Li", "B. Sun" ],
      "venue" : "Liu, Nanoscale 6 ",
      "citeRegEx" : "90",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Mater",
      "author" : [ "N. Wang", "F. Wei", "Y. Qi", "H. Li", "X. Lu", "G. Zhao", "Q. Xu", "ACS Appl" ],
      "venue" : "Inter. 6 ",
      "citeRegEx" : "91",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Adv",
      "author" : [ "S. Xu", "D. Li", "P. Wu" ],
      "venue" : "Funct. Mater. 25 ",
      "citeRegEx" : "92",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Y",
      "author" : [ "H. Ju", "L. Jia", "L. Ding", "J. Tian", "L. Bao" ],
      "venue" : "Hu, J.-S. Yu, Nanoscale 6 ",
      "citeRegEx" : "93",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Sci",
      "author" : [ "J. Li", "F. Jiang", "B. Yang", "X.R. Song", "Y. Liu", "H.H. Yang", "D.R. Cao", "W.R. Shi", "G.N. Chen" ],
      "venue" : "Rep. 3 ",
      "citeRegEx" : "94",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "H",
      "author" : [ "J. Kim" ],
      "venue" : "Kim, W.J. Kim, Small ",
      "citeRegEx" : "95",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Anal",
      "author" : [ "M. Pumera", "A.H. Loo", "TRAC Trend" ],
      "venue" : "Chem. 61 ",
      "citeRegEx" : "96",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "C.F. Zhu", "Z.Y. Zeng", "H. Li", "F. Li", "C.H. Fan", "H. Zhang", "J. Am" ],
      "venue" : "Soc. 135 ",
      "citeRegEx" : "97",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chem",
      "author" : [ "C. Tan", "P. Yu", "Y. Hu", "J. Chen", "Y. Huang", "Y. Cai", "Z. Luo", "B. Li", "Q. Lu", "L. Wang", "J. Am" ],
      "venue" : "Soc. 137 ",
      "citeRegEx" : "98",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Y",
      "author" : [ "G. Yang", "C. Zhu", "D. Du", "J. Zhu" ],
      "venue" : "Lin, Nanoscale 7 ",
      "citeRegEx" : "100",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "X",
      "author" : [ "J. Yu", "W. Yin", "X. Zheng", "G. Tian", "X. Zhang", "T. Bao", "X. Dong", "Z. Wang", "Z. Gu" ],
      "venue" : "Ma, Theranostics ",
      "citeRegEx" : "101",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Y",
      "author" : [ "W. Yin", "L. Yan", "J. Yu", "G. Tian", "L. Zhou", "X. Zheng", "X. Zhang", "Y. Yong", "J. Li", "Z. Gu" ],
      "venue" : "Zhao, ACS Nano 8 ",
      "citeRegEx" : "102",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "J",
      "author" : [ "S. Wang", "K. Li", "Y. Chen", "H. Chen", "M. Ma", "J. Feng", "Q. Zhao" ],
      "venue" : "Shi, Biomaterials 39 ",
      "citeRegEx" : "103",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "H",
      "author" : [ "Z. Yin", "H. Li", "H. Li", "L. Jiang", "Y. Shi", "Y. Sun", "G. Lu", "Q. Zhang", "X. Chen" ],
      "venue" : "Zhang, ACS Nano 6 ",
      "citeRegEx" : "104",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Chem",
      "author" : [ "Y. Li", "H. Wang", "L. Xie", "Y. Liang", "G. Hong", "H. Dai", "J. Am" ],
      "venue" : "Soc. 133 ",
      "citeRegEx" : "105",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Angew",
      "author" : [ "H. Ramakrishna Matte", "A. Gomathi", "A.K. Manna", "D.J. Late", "R. Datta", "S.K. Pati", "C. Rao" ],
      "venue" : "Chem. Int. Ed. 122 ",
      "citeRegEx" : "106",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "I",
      "author" : [ "T.F. Jaramillo", "K.P. Jørgensen", "J. Bonde", "J.H. Nielsen", "S. Horch" ],
      "venue" : "Chorkendorff, Science 317 ",
      "citeRegEx" : "107",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Chem",
      "author" : [ "Q. Xiang", "J. Yu", "M. Jaroniec", "J. Am" ],
      "venue" : "Soc. 134 ",
      "citeRegEx" : "108",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Nat",
      "author" : [ "B. Radisavljevic", "A. Kis" ],
      "venue" : "Mater. 12 ",
      "citeRegEx" : "109",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chem",
      "author" : [ "C. Tan", "Z. Liu", "W. Huang", "H. Zhang" ],
      "venue" : "Soc. Rev. 44 ",
      "citeRegEx" : "110",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "X",
      "author" : [ "W. Dai", "H. Dong", "B. Fugetsu", "Y. Cao", "H. Lu", "X. Ma" ],
      "venue" : "Zhang, Small 11 ",
      "citeRegEx" : "111",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Angew",
      "author" : [ "S.S. Chou", "B. Kaehr", "J. Kim", "B.M. Foley", "M. De", "P.E. Hopkins", "J. Huang", "C.J. Brinker", "V.P. Dravid" ],
      "venue" : "Chem. Int. Ed. 52 ",
      "citeRegEx" : "112",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Adv",
      "author" : [ "T. Liu", "C. Wang", "X. Gu", "H. Gong", "L. Cheng", "X. Shi", "L. Feng", "B. Sun", "Z. Liu" ],
      "venue" : "Mater. 26 ",
      "citeRegEx" : "113",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Z",
      "author" : [ "X. Qian", "S. Shen", "T. Liu", "L. Cheng" ],
      "venue" : "Liu, Nanoscale 7 ",
      "citeRegEx" : "114",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Z",
      "author" : [ "Y. Yong", "X. Cheng", "T. Bao", "M. Zu", "L. Yan", "W. Yin", "C. Ge", "D. Wang" ],
      "venue" : "Gu, Y.-l. Zhao, ACS Nano ",
      "citeRegEx" : "115",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "Q. Xiao", "X. Zheng", "W. Bu", "W. Ge", "S. Zhang", "F. Chen", "H. Xing", "Q. Ren", "W. Fan", "K. Zhao", "J. Am" ],
      "venue" : "Soc. 135 ",
      "citeRegEx" : "116",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Angew",
      "author" : [ "Z. Sun", "H. Xie", "S. Tang", "X.F. Yu", "Z. Guo", "J. Shao", "H. Zhang", "H. Huang", "H. Wang", "P.K. Chu" ],
      "venue" : "Chem. Int. Ed. 127 ",
      "citeRegEx" : "117",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "H. Wang", "X. Yang", "W. Shao", "S. Chen", "J. Xie", "X. Zhang", "J. Wang", "Y. Xie", "J. Am" ],
      "venue" : "Soc. 137 ",
      "citeRegEx" : "118",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Adv",
      "author" : [ "C.M. Park", "H.J. Sohn" ],
      "venue" : "Mater. 19 ",
      "citeRegEx" : "119",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Angew",
      "author" : [ "X. Zhang", "H. Xie", "Z. Liu", "C. Tan", "Z. Luo", "H. Li", "J. Lin", "L. Sun", "W. Chen", "Z. Xu" ],
      "venue" : "Chem. Int. Ed. 54 ",
      "citeRegEx" : "120",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "X",
      "author" : [ "J. Kang", "J.D. Wood", "S.A. Wells", "J.-H. Lee" ],
      "venue" : "Liu, K.-S. Chen, M.C. Hersam, ACS Nano 9 ",
      "citeRegEx" : "121",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Nat",
      "author" : [ "D. Hanlon", "C. Backes", "E. Doherty", "C.S. Cucinotta", "N.C. Berner", "C. Boland", "K. Lee", "A. Harvey", "P. Lynch", "Z. Gholamvand" ],
      "venue" : "Commun. 6 ",
      "citeRegEx" : "122",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Phys",
      "author" : [ "T. Vy", "R. Soklaski", "Y. Liang", "L. Yang" ],
      "venue" : "Rev. B 89 ",
      "citeRegEx" : "123",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Nat",
      "author" : [ "X.Q. Huang", "S.H. Tang", "X.L. Mu", "Y. Dai", "G.X. Chen", "Z.Y. Zhou", "F.X. Ruan", "Z.L. Yang", "N.F. Zheng" ],
      "venue" : "Nanotechnol. 6 ",
      "citeRegEx" : "124",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Adv",
      "author" : [ "M. Chen", "S. Tang", "Z. Guo", "X. Wang", "S. Mo", "X. Huang", "G. Liu", "N. Zheng" ],
      "venue" : "Mater. 26 ",
      "citeRegEx" : "125",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "H.L. Qin", "D. Wang", "Z.L. Huang", "D.M. Wu", "Z.C. Zeng", "B. Ren", "K. Xu", "J. Jin", "J. Am" ],
      "venue" : "Soc. 135 ",
      "citeRegEx" : "126",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "P",
      "author" : [ "R.R. Arvizo", "S. Bhattacharyya", "R.A. Kudgus", "K. Giri", "R. Bhattacharya" ],
      "venue" : "-carbonaceous materials-enabled efficient photothermal cancer .05.009  Mukherjee, Chem. Soc. Rev. 41 ",
      "citeRegEx" : "127",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Adv",
      "author" : [ "X. Huang", "S. Tang", "B. Liu", "B. Ren", "N. Zheng" ],
      "venue" : "Mater. 23 ",
      "citeRegEx" : "129",
      "shortCiteRegEx" : null,
      "year" : 2011
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Hyperthermia as an efficient cancer-treatment modality has ttracted broad research attentions of scientific community on ccount of its high efficiency for cancer-cell killing and specific role or enhancing the therapeutic outcome of other treatment modalties, such as chemotherapy and radiotherapy [1].",
      "startOffset" : 298,
      "endOffset" : 301
    }, {
      "referenceID" : 4,
      "context" : "Various heating modalities have been developed to generte the hot regions in tumors, including focused ultrasound [2–4], adiofrequency [5], magnetic field [1,6], microwave [7], light [8,9], tc.",
      "startOffset" : 135,
      "endOffset" : 138
    }, {
      "referenceID" : 0,
      "context" : "Various heating modalities have been developed to generte the hot regions in tumors, including focused ultrasound [2–4], adiofrequency [5], magnetic field [1,6], microwave [7], light [8,9], tc.",
      "startOffset" : 155,
      "endOffset" : 160
    }, {
      "referenceID" : 5,
      "context" : "Various heating modalities have been developed to generte the hot regions in tumors, including focused ultrasound [2–4], adiofrequency [5], magnetic field [1,6], microwave [7], light [8,9], tc.",
      "startOffset" : 155,
      "endOffset" : 160
    }, {
      "referenceID" : 6,
      "context" : "Various heating modalities have been developed to generte the hot regions in tumors, including focused ultrasound [2–4], adiofrequency [5], magnetic field [1,6], microwave [7], light [8,9], tc.",
      "startOffset" : 183,
      "endOffset" : 188
    }, {
      "referenceID" : 7,
      "context" : "Comparatively, photothermal therapy (PTT) features low cost, ite-specific therapy, mitigated side effects and relatively high effiiency [10].",
      "startOffset" : 136,
      "endOffset" : 140
    }, {
      "referenceID" : 19,
      "context" : "Carbon-based nanosystems including mesoporous caron [19–21], carbon nanodots[22,23] and graphene [24,25] were lso explored in biomedical applications, especially in phototheral therapy based on their strong light absorption in NIR region and orresponding high photothermal-conversion efficiency [26].",
      "startOffset" : 76,
      "endOffset" : 83
    }, {
      "referenceID" : 20,
      "context" : "Carbon-based nanosystems including mesoporous caron [19–21], carbon nanodots[22,23] and graphene [24,25] were lso explored in biomedical applications, especially in phototheral therapy based on their strong light absorption in NIR region and orresponding high photothermal-conversion efficiency [26].",
      "startOffset" : 76,
      "endOffset" : 83
    }, {
      "referenceID" : 21,
      "context" : "Carbon-based nanosystems including mesoporous caron [19–21], carbon nanodots[22,23] and graphene [24,25] were lso explored in biomedical applications, especially in phototheral therapy based on their strong light absorption in NIR region and orresponding high photothermal-conversion efficiency [26].",
      "startOffset" : 97,
      "endOffset" : 104
    }, {
      "referenceID" : 22,
      "context" : "Carbon-based nanosystems including mesoporous caron [19–21], carbon nanodots[22,23] and graphene [24,25] were lso explored in biomedical applications, especially in phototheral therapy based on their strong light absorption in NIR region and orresponding high photothermal-conversion efficiency [26].",
      "startOffset" : 97,
      "endOffset" : 104
    }, {
      "referenceID" : 23,
      "context" : "Carbon-based nanosystems including mesoporous caron [19–21], carbon nanodots[22,23] and graphene [24,25] were lso explored in biomedical applications, especially in phototheral therapy based on their strong light absorption in NIR region and orresponding high photothermal-conversion efficiency [26].",
      "startOffset" : 295,
      "endOffset" : 299
    }, {
      "referenceID" : 24,
      "context" : "Some rganic, inorganic and their hybrid nanosystems, such as polypyrole [27], indocyanine green[28], conductive polymers [29], CuS 30,31], Prussian blue [32], WOx [33], black TiO2 [34] and other rganic polymer/molecules[35,36] also provide alternative phoothermal agents for PTT.",
      "startOffset" : 72,
      "endOffset" : 76
    }, {
      "referenceID" : 25,
      "context" : "Some rganic, inorganic and their hybrid nanosystems, such as polypyrole [27], indocyanine green[28], conductive polymers [29], CuS 30,31], Prussian blue [32], WOx [33], black TiO2 [34] and other rganic polymer/molecules[35,36] also provide alternative phoothermal agents for PTT.",
      "startOffset" : 95,
      "endOffset" : 99
    }, {
      "referenceID" : 26,
      "context" : "Some rganic, inorganic and their hybrid nanosystems, such as polypyrole [27], indocyanine green[28], conductive polymers [29], CuS 30,31], Prussian blue [32], WOx [33], black TiO2 [34] and other rganic polymer/molecules[35,36] also provide alternative phoothermal agents for PTT.",
      "startOffset" : 121,
      "endOffset" : 125
    }, {
      "referenceID" : 29,
      "context" : "Some rganic, inorganic and their hybrid nanosystems, such as polypyrole [27], indocyanine green[28], conductive polymers [29], CuS 30,31], Prussian blue [32], WOx [33], black TiO2 [34] and other rganic polymer/molecules[35,36] also provide alternative phoothermal agents for PTT.",
      "startOffset" : 153,
      "endOffset" : 157
    }, {
      "referenceID" : 30,
      "context" : "Some rganic, inorganic and their hybrid nanosystems, such as polypyrole [27], indocyanine green[28], conductive polymers [29], CuS 30,31], Prussian blue [32], WOx [33], black TiO2 [34] and other rganic polymer/molecules[35,36] also provide alternative phoothermal agents for PTT.",
      "startOffset" : 163,
      "endOffset" : 167
    }, {
      "referenceID" : 31,
      "context" : "Some rganic, inorganic and their hybrid nanosystems, such as polypyrole [27], indocyanine green[28], conductive polymers [29], CuS 30,31], Prussian blue [32], WOx [33], black TiO2 [34] and other rganic polymer/molecules[35,36] also provide alternative phoothermal agents for PTT.",
      "startOffset" : 180,
      "endOffset" : 184
    }, {
      "referenceID" : 32,
      "context" : "Some rganic, inorganic and their hybrid nanosystems, such as polypyrole [27], indocyanine green[28], conductive polymers [29], CuS 30,31], Prussian blue [32], WOx [33], black TiO2 [34] and other rganic polymer/molecules[35,36] also provide alternative phoothermal agents for PTT.",
      "startOffset" : 219,
      "endOffset" : 226
    }, {
      "referenceID" : 33,
      "context" : "Some rganic, inorganic and their hybrid nanosystems, such as polypyrole [27], indocyanine green[28], conductive polymers [29], CuS 30,31], Prussian blue [32], WOx [33], black TiO2 [34] and other rganic polymer/molecules[35,36] also provide alternative phoothermal agents for PTT.",
      "startOffset" : 219,
      "endOffset" : 226
    }, {
      "referenceID" : 43,
      "context" : "Fortunately, ecent results have demonstrated that inorganic two-dimensional 2D) nanosheets with ultrathin atomic thickness, controllable ateral size, and extremely large surface area exhibit unique physochemical properties suitable for a broad range of applications, specially in biomedicine such as drug/gene delivery [43–45], iagnostic imaging [46,47], photothermal/photodynamic therapy 38], biosensing[48] and even tissue engineering [49].",
      "startOffset" : 346,
      "endOffset" : 353
    }, {
      "referenceID" : 44,
      "context" : "Fortunately, ecent results have demonstrated that inorganic two-dimensional 2D) nanosheets with ultrathin atomic thickness, controllable ateral size, and extremely large surface area exhibit unique physochemical properties suitable for a broad range of applications, specially in biomedicine such as drug/gene delivery [43–45], iagnostic imaging [46,47], photothermal/photodynamic therapy 38], biosensing[48] and even tissue engineering [49].",
      "startOffset" : 346,
      "endOffset" : 353
    }, {
      "referenceID" : 45,
      "context" : "Fortunately, ecent results have demonstrated that inorganic two-dimensional 2D) nanosheets with ultrathin atomic thickness, controllable ateral size, and extremely large surface area exhibit unique physochemical properties suitable for a broad range of applications, specially in biomedicine such as drug/gene delivery [43–45], iagnostic imaging [46,47], photothermal/photodynamic therapy 38], biosensing[48] and even tissue engineering [49].",
      "startOffset" : 404,
      "endOffset" : 408
    }, {
      "referenceID" : 46,
      "context" : "Fortunately, ecent results have demonstrated that inorganic two-dimensional 2D) nanosheets with ultrathin atomic thickness, controllable ateral size, and extremely large surface area exhibit unique physochemical properties suitable for a broad range of applications, specially in biomedicine such as drug/gene delivery [43–45], iagnostic imaging [46,47], photothermal/photodynamic therapy 38], biosensing[48] and even tissue engineering [49].",
      "startOffset" : 437,
      "endOffset" : 441
    }, {
      "referenceID" : 47,
      "context" : "Graphene-based 2D nanosheets have been extensively xplored as the efficient photothermal agents for tumor hyperhermia [50].",
      "startOffset" : 118,
      "endOffset" : 122
    }, {
      "referenceID" : 64,
      "context" : ", these multifunctional 2D nanomateirals possess theranostic functions (concurrent diagnostic imaging and therapy) [67].",
      "startOffset" : 115,
      "endOffset" : 119
    }, {
      "referenceID" : 51,
      "context" : "Transition metal dichalcogenides (TMDCs) are a new family of 2D nanosheets typically in the form of MX2 where M is the transition metal and X is the chalcogen [54,62,68].",
      "startOffset" : 159,
      "endOffset" : 169
    }, {
      "referenceID" : 59,
      "context" : "Transition metal dichalcogenides (TMDCs) are a new family of 2D nanosheets typically in the form of MX2 where M is the transition metal and X is the chalcogen [54,62,68].",
      "startOffset" : 159,
      "endOffset" : 169
    }, {
      "referenceID" : 65,
      "context" : "Transition metal dichalcogenides (TMDCs) are a new family of 2D nanosheets typically in the form of MX2 where M is the transition metal and X is the chalcogen [54,62,68].",
      "startOffset" : 159,
      "endOffset" : 169
    }, {
      "referenceID" : 71,
      "context" : ", WS2 and Bi2Se3) can be dopted for contrast-enhanced X-ray computed tomography (CT) maging and sensitization-enhanced radiation therapy (RT) [75,94].",
      "startOffset" : 142,
      "endOffset" : 149
    }, {
      "referenceID" : 90,
      "context" : ", WS2 and Bi2Se3) can be dopted for contrast-enhanced X-ray computed tomography (CT) maging and sensitization-enhanced radiation therapy (RT) [75,94].",
      "startOffset" : 142,
      "endOffset" : 149
    }, {
      "referenceID" : 91,
      "context" : "he unique sheet-like topology with large surface area can be utiized to encapsulate and deliver therapeutic molecules, such as nticancer drugs and therapeutic genes [95].",
      "startOffset" : 165,
      "endOffset" : 169
    }, {
      "referenceID" : 73,
      "context" : "Moreover, TMDCs ith unprecedented physiochemical property were demonstrated o be effective in biosensing areas [77,86,96,97].",
      "startOffset" : 111,
      "endOffset" : 124
    }, {
      "referenceID" : 82,
      "context" : "Moreover, TMDCs ith unprecedented physiochemical property were demonstrated o be effective in biosensing areas [77,86,96,97].",
      "startOffset" : 111,
      "endOffset" : 124
    }, {
      "referenceID" : 92,
      "context" : "Moreover, TMDCs ith unprecedented physiochemical property were demonstrated o be effective in biosensing areas [77,86,96,97].",
      "startOffset" : 111,
      "endOffset" : 124
    }, {
      "referenceID" : 93,
      "context" : "Moreover, TMDCs ith unprecedented physiochemical property were demonstrated o be effective in biosensing areas [77,86,96,97].",
      "startOffset" : 111,
      "endOffset" : 124
    }, {
      "referenceID" : 107,
      "context" : "onversion efficiency, indicating that they can act as photothermal gent for PTT [112].",
      "startOffset" : 80,
      "endOffset" : 85
    }, {
      "referenceID" : 108,
      "context" : "The ultrathin MoS2 nanosheets not only can act as the photothermal agent for PTT, but also function as the drug-delivery nanocarriers for chemotherapeutic agents based on their large surface area [113].",
      "startOffset" : 196,
      "endOffset" : 201
    }, {
      "referenceID" : 97,
      "context" : "M M [ n 1 a P 4 a t t m w umor at the end of each treatment [102].",
      "startOffset" : 60,
      "endOffset" : 65
    }, {
      "referenceID" : 91,
      "context" : "As a paradigm, MoS2 surface was co-modified with polyethyleneimine (PEI) and polyethylenglycol (PEG) via reducingresponsive disulfide bonds (designated as MoS2-PEI-PEG) [95].",
      "startOffset" : 169,
      "endOffset" : 173
    }, {
      "referenceID" : 71,
      "context" : "4a) with high-content W compoent are favorable for CT imaging due to high atomic number (Z) of element (Z = 74) [75].",
      "startOffset" : 112,
      "endOffset" : 116
    }, {
      "referenceID" : 90,
      "context" : "4c1) were recently shown as photothermal agents for efficient PTT [94].",
      "startOffset" : 66,
      "endOffset" : 70
    }, {
      "referenceID" : 110,
      "context" : "On this ground, ultrasmall WS2 QDs were esigned as both radiosensitizer and photothermal-conversion gent for simultaneous RT and PTT [115].",
      "startOffset" : 133,
      "endOffset" : 138
    }, {
      "referenceID" : 111,
      "context" : "t is noted that PTT is reported to be effective in killing the caner cells those are not sensitive to RT procedure [116].",
      "startOffset" : 115,
      "endOffset" : 120
    }, {
      "referenceID" : 112,
      "context" : "Very ecently, BP nanosheets were demonstrated to act as exceptional hotothermal-conversion agent for efficient tumor hyperthermia nd photosensitizer for photodynamic therapy [117,118].",
      "startOffset" : 174,
      "endOffset" : 183
    }, {
      "referenceID" : 113,
      "context" : "Very ecently, BP nanosheets were demonstrated to act as exceptional hotothermal-conversion agent for efficient tumor hyperthermia nd photosensitizer for photodynamic therapy [117,118].",
      "startOffset" : 174,
      "endOffset" : 183
    }, {
      "referenceID" : 118,
      "context" : "As an metal-free semiconductor, P nanosheets are capable of generating singlet oxygen based on heir unique electronic structure [123].",
      "startOffset" : 128,
      "endOffset" : 133
    }, {
      "referenceID" : 113,
      "context" : "It was recently demontrated that BP nanosheets could produce (1)O2 under the irradiation f entire visible light [118].",
      "startOffset" : 112,
      "endOffset" : 117
    }, {
      "referenceID" : 119,
      "context" : "To overcome the drawbacks of low photothermal stability of conventional plasmonic Au and Ag NPs, metal palladium (Pd) nanosheets with strong NIR SPR absorption and enhanced photothermal stability were synthesized by a generic CO-confined growth approach [124].",
      "startOffset" : 254,
      "endOffset" : 259
    }, {
      "referenceID" : 119,
      "context" : "microscopic images of cells after irradiation for (i) 2 min and (j) 5 min (Trypan blue was used to stain dead cells).[124].",
      "startOffset" : 117,
      "endOffset" : 122
    }, {
      "referenceID" : 120,
      "context" : "The growth of Au shell onto the urface of Pd nanosheets was realized by reducing AuPPh3Cl with ydrazine hydrate [125].",
      "startOffset" : 112,
      "endOffset" : 117
    }, {
      "referenceID" : 123,
      "context" : "Furthermore, coating an Ag layer onto the surface of Pd anosheets (Pd@Ag) could improve the photothermal stability of lasmonic metal nanoplates based on high photothermal stability f inner Pd nanosheets [129].",
      "startOffset" : 203,
      "endOffset" : 208
    }, {
      "referenceID" : 5,
      "context" : "It is also noted that such an injection mode based on liquid-solid phase-changing implants can firmly restrict the photothermal agents within the tumor tissue, thus the cytotoxicity to normal organs is significantly mitigated [6].",
      "startOffset" : 226,
      "endOffset" : 229
    }, {
      "referenceID" : 112,
      "context" : "For black phosphorous (BP), the cytotoxicity of PQDs was assessed by a standard MTT assay against four types f cells, including HSC, 293T, C6 and MCF7 cells [117].",
      "startOffset" : 157,
      "endOffset" : 162
    }, {
      "referenceID" : 42,
      "context" : "ally have large surface area and high surface-to-volume ratio or anchoring guest molecules and corresponding sustained drug eleasing [45,47], which is the typical feature of mesoporous aterials for drug delivery [19,44,166,169–176].",
      "startOffset" : 133,
      "endOffset" : 140
    }, {
      "referenceID" : 44,
      "context" : "ally have large surface area and high surface-to-volume ratio or anchoring guest molecules and corresponding sustained drug eleasing [45,47], which is the typical feature of mesoporous aterials for drug delivery [19,44,166,169–176].",
      "startOffset" : 133,
      "endOffset" : 140
    } ],
    "year" : 2016,
    "abstractText" : "Based on the unique two-dimensional (2D) planar nanostructure with atomic-thin thickness, abundant composition variations and the corresponding exceptional physiochemical/biological performances, the emerging inorganic 2D nanomaterials with high biocompatibility have been becoming one of the most promising material nanosystems of great potentials for applications in biomedicine. This review focuses on the unique photothermal-conversion property of several new representative 2D nanomaterials beyond graphene for photothermal conversion-based tumor hyperthermia and theranostic biomedicine, including transition metal dichalcogenides (TMDCs, such as MoS2, WS2, TiS2 and Bi2Se3), black phosphorous (P), metal Pd nanosheets and their composite nanosheets. Based on high photothermal-conversion efficiency of these 2D nanomaterials, this review first highlights the design, synthesis and surface functionalization of 2D nanomaterials for photothermal therapy (PTT) ablation of cancer cells/tissues. The representative strategies of functionalizing these 2D nanomaterials for imaging-guided PTT and PTTbased synergistic cancer therapy are then discussed. The preliminary progresses on biosafety evaluation of these 2D nanomaterials were also briefly summarized and discussed. Finally, we discussed the state-ofart unsolved critical issues and challenges, and outlooked further research directions of 2D nanomaterials for potential clinical translation for PTT tumor ablation. It is believed that the fast development and promising performance of these biocompatible 2D materials can provide a highly efficient nanoplatform for combating cancer by hyperthermia. © 2016 Elsevier Ltd. All rights reserved.",
    "creator" : "Elsevier"
  }
}